EP4505884A1 - Smokeless article - Google Patents
Smokeless article Download PDFInfo
- Publication number
- EP4505884A1 EP4505884A1 EP23190375.8A EP23190375A EP4505884A1 EP 4505884 A1 EP4505884 A1 EP 4505884A1 EP 23190375 A EP23190375 A EP 23190375A EP 4505884 A1 EP4505884 A1 EP 4505884A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- content
- powdered cellulose
- less
- examples
- smokeless
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000001913 cellulose Substances 0.000 claims abstract description 121
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 101
- 235000019814 powdered cellulose Nutrition 0.000 claims abstract description 98
- 229920003124 powdered cellulose Polymers 0.000 claims abstract description 98
- 239000002245 particle Substances 0.000 claims abstract description 65
- 239000000796 flavoring agent Substances 0.000 claims abstract description 24
- 239000013543 active substance Substances 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 41
- 229960002715 nicotine Drugs 0.000 claims description 33
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 33
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 32
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 31
- 241000196324 Embryophyta Species 0.000 claims description 28
- 241000208125 Nicotiana Species 0.000 claims description 28
- 235000010980 cellulose Nutrition 0.000 claims description 23
- 229920002678 cellulose Polymers 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 13
- -1 nicotine salt Chemical class 0.000 claims description 7
- 230000008447 perception Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 20
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 26
- 235000017491 Bambusa tulda Nutrition 0.000 description 26
- 241001330002 Bambuseae Species 0.000 description 26
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 26
- 239000011425 bamboo Substances 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 14
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 14
- 239000008108 microcrystalline cellulose Substances 0.000 description 14
- 229940016286 microcrystalline cellulose Drugs 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 14
- 210000003296 saliva Anatomy 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- 239000004067 bulking agent Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 239000000945 filler Substances 0.000 description 9
- 239000003906 humectant Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 7
- 235000003599 food sweetener Nutrition 0.000 description 7
- 239000003765 sweetening agent Substances 0.000 description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 5
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- 239000000619 acesulfame-K Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 239000007967 peppermint flavor Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 235000012665 annatto Nutrition 0.000 description 4
- 235000010216 calcium carbonate Nutrition 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920003043 Cellulose fiber Polymers 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000001670 anatto Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 235000012730 carminic acid Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 239000004148 curcumin Substances 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000623620 Andersonglossum virginianum Species 0.000 description 2
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 2
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000045231 Canavalia maritima Species 0.000 description 2
- 235000010522 Canavalia maritima Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 244000061408 Eugenia caryophyllata Species 0.000 description 2
- 239000004211 Flavoxanthin Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- 241001293495 Lactuca virosa Species 0.000 description 2
- 240000007890 Leonurus cardiaca Species 0.000 description 2
- 240000002817 Leonurus sibiricus Species 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 240000009215 Nepeta cataria Species 0.000 description 2
- 235000010679 Nepeta cataria Nutrition 0.000 description 2
- 241000050054 Pedicularis groenlandica Species 0.000 description 2
- 240000002264 Phyllostachys aurea Species 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000004216 Rhodoxanthin Substances 0.000 description 2
- 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 235000003591 Tagetes lucida Nutrition 0.000 description 2
- 240000002670 Tagetes lucida Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 240000000143 Turnera diffusa Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000004234 Yellow 2G Substances 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 2
- 235000012741 allura red AC Nutrition 0.000 description 2
- 239000004191 allura red AC Substances 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 235000010210 aluminium Nutrition 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 235000012733 azorubine Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 2
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 2
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 2
- 235000012709 brilliant black BN Nutrition 0.000 description 2
- 239000004126 brilliant black BN Substances 0.000 description 2
- 235000012745 brilliant blue FCF Nutrition 0.000 description 2
- 239000004161 brilliant blue FCF Substances 0.000 description 2
- 235000012713 brown FK Nutrition 0.000 description 2
- 239000004109 brown FK Substances 0.000 description 2
- 235000012670 brown HT Nutrition 0.000 description 2
- 239000001678 brown HT Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000004106 carminic acid Substances 0.000 description 2
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000012732 erythrosine Nutrition 0.000 description 2
- 239000004174 erythrosine Substances 0.000 description 2
- 235000012656 ethyl ester of beta-apo-8'-carotenic acid Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019243 flavoxanthin Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 235000012738 indigotine Nutrition 0.000 description 2
- 239000004179 indigotine Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 235000010187 litholrubine BK Nutrition 0.000 description 2
- 239000004335 litholrubine BK Substances 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 239000004180 red 2G Substances 0.000 description 2
- 235000012739 red 2G Nutrition 0.000 description 2
- 235000019246 rhodoxanthin Nutrition 0.000 description 2
- 235000019234 riboflavin-5-sodium phosphate Nutrition 0.000 description 2
- 235000009514 rubixanthin Nutrition 0.000 description 2
- 239000000455 rubixanthin Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000012751 sunset yellow FCF Nutrition 0.000 description 2
- 239000004173 sunset yellow FCF Substances 0.000 description 2
- 235000013706 tagetes lucida Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 239000004149 tartrazine Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- 235000004952 turnera diffusa Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000019235 yellow 2G Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- RFEJUZJILGIRHQ-OMDKHLBYSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 RFEJUZJILGIRHQ-OMDKHLBYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940083957 1,2-butanediol Drugs 0.000 description 1
- QLDPCHZQQIASHX-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.CN1CCCC1C1=CC=CN=C1 QLDPCHZQQIASHX-UHFFFAOYSA-N 0.000 description 1
- JMEVHYCNAPFOAB-UHFFFAOYSA-N 2-(3-hydroxy-5-sulfo-1H-indol-2-yl)-3-oxoindole-5-sulfonic acid Chemical compound Oc1c([nH]c2ccc(cc12)S(O)(=O)=O)C1=Nc2ccc(cc2C1=O)S(O)(=O)=O JMEVHYCNAPFOAB-UHFFFAOYSA-N 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- MQWJVKLIBZWVEL-XRIOVQLTSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;dihydrochloride Chemical compound Cl.Cl.CN1CCC[C@H]1C1=CC=CN=C1 MQWJVKLIBZWVEL-XRIOVQLTSA-N 0.000 description 1
- HDJBTCAJIMNXEW-PPHPATTJSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;hydrochloride Chemical compound Cl.CN1CCC[C@H]1C1=CC=CN=C1 HDJBTCAJIMNXEW-PPHPATTJSA-N 0.000 description 1
- YHBIGBYIUMCLJS-UHFFFAOYSA-N 5-fluoro-1,3-benzothiazol-2-amine Chemical compound FC1=CC=C2SC(N)=NC2=C1 YHBIGBYIUMCLJS-UHFFFAOYSA-N 0.000 description 1
- DFMMVLFMMAQXHZ-DOKBYWHISA-N 8'-apo-beta,psi-caroten-8'-al Chemical compound O=CC(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-DOKBYWHISA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- CEZCCHQBSQPRMU-LLIZZRELSA-L Allura red AC Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1\N=N\C1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-LLIZZRELSA-L 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 235000011908 Amaranthus dubius Nutrition 0.000 description 1
- 240000006421 Amaranthus dubius Species 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 240000000058 Argemone mexicana Species 0.000 description 1
- 235000004355 Artemisia lactiflora Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001330024 Bambusoideae Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000985665 Cecropia obtusifolia Species 0.000 description 1
- 241001480010 Cestrum Species 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 239000004217 Citranaxanthin Substances 0.000 description 1
- SLQHGWZKKZPZEK-JKEZLOPUSA-N Citranaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C SLQHGWZKKZPZEK-JKEZLOPUSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001194784 Entada rheedei Species 0.000 description 1
- OBSYBRPAKCASQB-UHFFFAOYSA-N Episalvinorin A Natural products COC(=O)C1CC(OC(C)=O)C(=O)C(C2(C3)C)C1(C)CCC2C(=O)OC3C=1C=COC=1 OBSYBRPAKCASQB-UHFFFAOYSA-N 0.000 description 1
- 241000218182 Eschscholzia Species 0.000 description 1
- 244000001381 Eschscholzia californica Species 0.000 description 1
- 244000062175 Fittonia argyroneura Species 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000700201 Galea Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000000224 Hippobroma longiflora Species 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- 241000218229 Humulus japonicus Species 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000274638 Laggera alata Species 0.000 description 1
- 244000253077 Leonotis leonurus Species 0.000 description 1
- 235000017143 Leonurus cardiaca Nutrition 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 235000002434 Leonurus sibiricus Nutrition 0.000 description 1
- 240000008496 Lobelia cardinalis Species 0.000 description 1
- 241000968111 Lobelia inflata Species 0.000 description 1
- 240000009166 Lobelia siphilitica Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000061322 Nicotiana alata Species 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- 241001480177 Nymphaea alba Species 0.000 description 1
- 235000002195 Nymphaea caerulea Nutrition 0.000 description 1
- 240000009085 Nymphaea caerulea Species 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 241000218996 Passiflora Species 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 240000008440 Passiflora incarnata Species 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 241000614197 Pedicularis densiflora Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- 239000004228 Riboflavin-5'-Phosphate Substances 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000011771 Salvia divinorum Nutrition 0.000 description 1
- 241001136613 Salvia divinorum Species 0.000 description 1
- 241001226049 Salvia dorrii Species 0.000 description 1
- 235000016274 Salvia dorrii Nutrition 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 235000010495 Sarothamnus scoparius Nutrition 0.000 description 1
- 241000519989 Scutellaria galericulata Species 0.000 description 1
- 241000632296 Scutellaria lateriflora Species 0.000 description 1
- 244000191704 Sida acuta Species 0.000 description 1
- 235000002834 Sida rhombifolia Nutrition 0.000 description 1
- 240000003194 Sida rhombifolia Species 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 description 1
- 235000005701 Tarchonanthus camphoratus Nutrition 0.000 description 1
- 244000082946 Tarchonanthus camphoratus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241001530097 Verbascum Species 0.000 description 1
- 244000178289 Verbascum thapsus Species 0.000 description 1
- 235000010599 Verbascum thapsus Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 241000211124 Zamia muricata Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- ANVAOWXLWRTKGA-XDECGSRTSA-N alfa-carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XDECGSRTSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- SZCBXWMUOPQSOX-WVJDLNGLSA-N all-trans-violaxanthin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-WVJDLNGLSA-N 0.000 description 1
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WXLFIFHRGFOVCD-UHFFFAOYSA-L azophloxine Chemical compound [Na+].[Na+].OC1=C2C(NC(=O)C)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 WXLFIFHRGFOVCD-UHFFFAOYSA-L 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- TVWOWDDBXAFQDG-DQRAZIAOSA-N azorubine Chemical compound C1=CC=C2C(\N=N/C3=C(C4=CC=CC=C4C(=C3)S(O)(=O)=O)O)=CC=C(S(O)(=O)=O)C2=C1 TVWOWDDBXAFQDG-DQRAZIAOSA-N 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940055580 brilliant blue fcf Drugs 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960003609 cathine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
- 229950002698 cathinone Drugs 0.000 description 1
- PUAQLLVFLMYYJJ-ZETCQYMHSA-N cathinone Chemical compound C[C@H](N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-ZETCQYMHSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- JYNBEDVXQNFTOX-UHFFFAOYSA-N chembl2008134 Chemical compound OS(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C(O)=O)=CC2=CC=CC=C12 JYNBEDVXQNFTOX-UHFFFAOYSA-N 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000019247 citranaxanthin Nutrition 0.000 description 1
- PRDJTOVRIHGKNU-ZWERVMMHSA-N citranaxanthin Chemical compound CC(=O)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-ZWERVMMHSA-N 0.000 description 1
- PRDJTOVRIHGKNU-UHFFFAOYSA-N citranaxanthine Natural products CC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000019806 copper complexes of chlorophyll Nutrition 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- FTZLWXQKVFFWLY-UHFFFAOYSA-L disodium;2,5-dichloro-4-[3-methyl-5-oxo-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazol-1-yl]benzenesulfonate Chemical compound [Na+].[Na+].CC1=NN(C=2C(=CC(=C(Cl)C=2)S([O-])(=O)=O)Cl)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 FTZLWXQKVFFWLY-UHFFFAOYSA-L 0.000 description 1
- TUQJHVRCALPCHU-QPRXZMCZSA-L disodium;4-[(2z)-2-[(5e)-3-(hydroxymethyl)-4,6-dioxo-5-[(4-sulfonatonaphthalen-1-yl)hydrazinylidene]cyclohex-2-en-1-ylidene]hydrazinyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].C1=CC=C2C(N/N=C3/C(=O)C(=N\NC=4C5=CC=CC=C5C(=CC=4)S([O-])(=O)=O)/C=C(C3=O)CO)=CC=C(S([O-])(=O)=O)C2=C1 TUQJHVRCALPCHU-QPRXZMCZSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- ZDKZHVNKFOXMND-UHFFFAOYSA-N epinepetalactone Chemical compound O=C1OC=C(C)C2C1C(C)CC2 ZDKZHVNKFOXMND-UHFFFAOYSA-N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000001684 ethyl ester of beta-apo-8'-carotenic acid (C30) Substances 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000012767 functional filler Substances 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- 239000004407 iron oxides and hydroxides Substances 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 150000002559 kavalactones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- LDMPZNTVIGIREC-ZGPNLCEMSA-N nicotine bitartrate Chemical compound O.O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 LDMPZNTVIGIREC-ZGPNLCEMSA-N 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 210000005179 oral vestibule Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000006502 papoula Nutrition 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- OBSYBRPAKCASQB-AGQYDFLVSA-N salvinorin A Chemical compound C=1([C@H]2OC(=O)[C@@H]3CC[C@]4(C)[C@@H]([C@]3(C2)C)C(=O)[C@@H](OC(C)=O)C[C@H]4C(=O)OC)C=COC=1 OBSYBRPAKCASQB-AGQYDFLVSA-N 0.000 description 1
- IQXUYSXCJCVVPA-UHFFFAOYSA-N salvinorin A Natural products CC(=O)OC1CC(OC(=O)C)C2(C)CCC34CC(CC3(C)C2C1=O)(OC4=O)c5occc5 IQXUYSXCJCVVPA-UHFFFAOYSA-N 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- YJCJAUSWVUZMSY-UHFFFAOYSA-K trisodium;4-[(2,4-diamino-5-methylphenyl)diazenyl]benzenesulfonate;4-[[2,4-diamino-5-[(4-sulfonatophenyl)diazenyl]phenyl]diazenyl]benzenesulfonate Chemical compound [Na+].[Na+].[Na+].C1=C(N)C(C)=CC(N=NC=2C=CC(=CC=2)S([O-])(=O)=O)=C1N.NC1=CC(N)=C(N=NC=2C=CC(=CC=2)S([O-])(=O)=O)C=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 YJCJAUSWVUZMSY-UHFFFAOYSA-K 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- BRTHFWPGJMGHIV-UHFFFAOYSA-L zinc;3-(1-methylpyrrolidin-2-yl)pyridine;dichloride;hydrate Chemical compound O.[Cl-].[Cl-].[Zn+2].CN1CCCC1C1=CC=CN=C1 BRTHFWPGJMGHIV-UHFFFAOYSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical class N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
Definitions
- the present disclosure relates to a smokeless article.
- the disclosure relates to a smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and a nicotinic compound, wherein the powdered cellulose has an average particle size of 100-500 ⁇ m.
- the disclosure also relates to the use of a content, the content comprising powdered cellulose and a nicotinic compound.
- Smokeless articles are a suitable alternative to conventional cigarettes because they do not require heating for substance delivery to the user. Instead, smokeless articles rely on saliva to extract soluble substances, typically nicotine and/or flavours, from tobacco contained within the smokeless article.
- Smokeless articles are placed in the mouth where saliva extracts the soluble element from the content contained within.
- the smokeless article is placed in the oral cavity, sublingually or in the oral vestibule (between the teeth and lips/cheeks).
- the user may assist extraction by oral manipulation, such as by chewing and/or sucking or pressing on the outside of the mouth to squeeze the pouch.
- Snuff is smokeless tobacco made from ground or pulverised tobacco leaves. Snuff is available in dry form or wet (moist) form. Moist snuff may be referred to as snus. Two common varieties of snus are Scandinavian snus and American snus. Both varieties of snus are available in a loose form, but are often contained within a saliva permeable pouch.
- the present disclosure relates to a smokeless article e.g. an oral nicotine delivery (OND) article for oral use.
- OND oral nicotine delivery
- the present disclosure provides in a first aspect a smokeless article for oral consumption comprising a pouch enclosing a content.
- the content comprises powdered cellulose and an active agent and/or flavourant, wherein the powdered cellulose has an average particle size of 100-500 ⁇ m.
- a smokeless article comprising powdered cellulose of a particle size within this range leads to improved properties of the content and the article itself.
- the resultant content has a lower Carr's Index (indicating improved compressibility) and a lower Hausner's Ratio (indicating improved flowability) than contents prepared with powdered cellulose having an average particle size outside this range.
- the improved flowability and/or compressibility of the content is itself advantageous because it improves the handling of the powder during manufacture.
- the powder has improved compressibility and/or flowability, it is possible to increase the amount of water in the content beyond what would normally be possible, while still maintaining acceptable compressibility and flowability.
- the user's perception of the active agent and/or flavourant can be improved, because a higher water content causes the perceived active agent content or flavourant content of the smokeless article to be increased.
- the end result is a smokeless article which seems "stronger" to the user, which is desirable to many users.
- the powdered cellulose within this particle size range improves the mouth feel of the smokeless article which has a positive impact on the consumer's experience.
- the presence of powdered cellulose with an average particle size of 100-500 ⁇ m therefore delivers a smokeless article which is easier to manufacture due to improved compressibility and/or flowability of the constituent content, which may deliver a more intense experience to the user, and which also improves mouth feel.
- oral consumption is intended to refer to any oral administration route achieved by placing the smokeless article into the oral cavity. This includes, but is not limited to, buccal, sub-lingual, periodontal, gingival and ingestion.
- the smokeless article may be an oral nicotine delivery (OND) article when the active agent within the content comprises a nicotinic compound.
- OND oral nicotine delivery
- the active agent comprises or consists of an active compound. In some examples the active agent comprises or consists of a nicotinic compound.
- the smokeless article comprises a pouch enclosing a content, wherein the content (including e.g. a nicotinic compound and non-tobacco plant material fibres) is completely enclosed by the pouch.
- the pouch is sealed to ensure that the contents of the pouch does not scatter inside the mouth.
- the smokeless article may have a mass of about 0.1 g to 5.0 g, such as about 0.5 g to about 4.0 g or about 1.0 g to about 3.0 g.
- the smokeless article may have a length of about 30 mm, such as about 28 mm or 26 mm, a width of about 12 mm, such as about 10 mm or 8 mm, and a depth of about 5 mm, such as about 4 mm or 3 mm.
- the smokeless article may have an active lifetime of about 20 minutes to about 60 minutes, such as about 25 minutes to 50 minutes or about 30 minutes to about 45 minutes, after being placed in the mouth.
- active lifetime is intended to refer to the amount of time after being placed in the mouth that the smokeless article provides the user with a perceptible taste and/or physiological experience.
- the active lifetime may be defined as the in use period of time in which 90%wt of the available pharmacologically active is released.
- the active lifetime may be the duration of time from insertion into the oral cavity for 90%wt of the total amount of nicotine pharmacologically active ingredient that is capable of being released during normal use to dissolve into the user's saliva and /or enter the user's bloodstream. It will therefore be appreciated that the active lifetime of a product may vary from user to user and for a user based on oral conditions, in particular extent of salivation. Nonetheless, the skilled person is able to mimic oral conditions to determine the active lifetime in one instance, which can be used as a comparison or analysis point.
- the pouch may be formed from one or more materials.
- the pouch material may be formed from fiber, paper, cloth and fabric.
- the pouch material may be formed from one or more polymeric materials.
- the polymeric material may be selected from one or more of hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol (PVOH), polyvinylpyrrolidone (PVP), polyethylene oxide (PEO) hydroxyethyl cellulose (HEC), polyethylene glycol (PEG), pullulan, sodium alginate, xanthan gum, tragancanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, maltodextrin, methylmethacrylate copolymer, carboxyvinyl copolymers, starch and gelatin.
- HPC hydroxypropyl cellulose
- HPMC hydroxypropyl methylcellulose
- PVH polyvinyl alcohol
- PVP polyvinylpyrrolidone
- the pouch is typically completely insoluble in saliva.
- Suitable insoluble pouch materials include, but are not limited to, fiber, paper, water-insoluble polymers, cloth and fabric.
- Suitable soluble pouch materials include, but are not limited to, water-soluble polymers such as polyethylene oxide (PEO), hydroxypropyl cellulose (HPC) and hydroxypropyl methylcellulose (HPMC).
- the pouch may be formed by, for example, folding a single sheet on itself or bringing two or more sheets together and sealing the edges.
- the edges may initially be partially sealed to provide an open pouch in which the content (e.g. a nicotinic compound and non-tobacco plant material fibres) may be placed before completely sealing the pouch closed.
- the sheets may be the same thickness or different thicknesses.
- the pouch is porous.
- at least 50% of the pores have a diameter of 50 ⁇ m to 200 ⁇ m, such as 100 ⁇ m to 175 ⁇ m or 125 ⁇ m or 150 ⁇ m.
- at least 50% of the pores have a diameter of at least 100 ⁇ m.
- at least 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% of the pores have such diameters.
- the pouch may be coloured or include markings, such as brand logos and text, to improve user perception.
- the pouch may be partially or completely coloured by a colourant.
- the powdered cellulose has an average particle size above 200 ⁇ m, for example above 250 ⁇ m, above 280 ⁇ m, above 290 ⁇ m, above 300 ⁇ m, or above 310 ⁇ m.
- the powdered cellulose has an average particle size of up to 450 ⁇ m, for example up to 400 ⁇ m, up to 350 ⁇ m, up to 340 ⁇ m, up to 330 ⁇ m, or up to 320 ⁇ m.
- the powdered cellulose has an average particle size of 150-500 ⁇ m, for example 200-500 ⁇ m, 250-500 ⁇ m, 300-500 ⁇ m, 300-450 ⁇ m, 300-400 ⁇ m, or 300-350 ⁇ m.
- the powdered cellulose has an average particle size of 250-450 ⁇ m.
- the powdered cellulose has an average particle size of about 320 ⁇ m.
- the powdered cellulose has a bulk density above about 0.20 g/mL, for example above about 0.25 g/mL, above about 0.28 g/mL, or above about 0.30 g/mL.
- the powdered cellulose has a bulk density up to about 0.48 g/mL, for example up to about 0.46 g/mL, up to about 0.44 g/mL, up to about 0.43 g/mL, or up to about 0.42 g/mL.
- the powdered cellulose has a bulk density of 0.20-0.5 g/mL, 0.25-0.5 g/mL, 0.28-0.5 g/mL, 0.30-0.5 g/mL, 0.30-0.45 g/mL, or 0.30-0.42 g/mL.
- the powdered cellulose has a bulk density of 0.30-0.45 g/mL, for example 0.30-0.40 g/mL.
- the powdered cellulose has a bulk density of about 0.35 g/mL.
- the bulk density may be determined according to the method in DIN EN ISO 60.
- the powdered cellulose has an average particle size of 150-500 ⁇ m and a bulk density of 0.20-0.5 g/mL, for example an average particle size of 200-500 ⁇ m and a bulk density of 0.25-0.5 g/mL, an average particle size of 250-500 ⁇ m and a bulk density of 0.25-0.5 g/mL, or an average particle size of 250-500 ⁇ m and a bulk density of 0.28-0.5 g/mL.
- the powdered cellulose has an average particle size of 250-450 ⁇ m and a bulk density of 0.30-0.45 g/mL. In some examples, the powdered cellulose has an average particle size of 250-350 ⁇ m and a bulk density of 0.30-0.40 g/mL.
- the powdered cellulose has an average particle size of about 320 ⁇ m and a bulk density of about 0.35 g/mL.
- the powdered cellulose has an angle of repose of at least 30°, for example at least 32°, at least 34° or at least 36°. In some examples, the powdered cellulose has an angle of repose of up to 48°, for example up to 46°, up to 44°, up to 42°, up to 40°, up to 38° or up to 36°. In some examples, the powdered cellulose has an angle of repose of from 30° to 48°, for example from 30° to 44°, from 30° to 40°, from 32° to 40° or from 34° to 38. Angle of repose is a measure of powder flowability and may be determined by the method in ISO 4324.
- the term 'powdered cellulose' refers to a plant-based functional filler.
- the powdered cellulose comprises a mechanically-processed cellulose derivative with a fibrous structure.
- the mechanically processed cellulose derivative is purified.
- the powdered cellulose is mechanically-disintegrated cellulose prepared by processing ⁇ -cellulose.
- the powdered cellulose comprises a purified mechanically processed cellulose derivative with a fibrous structure, which is prepared by processing ⁇ -cellulose.
- the powdered cellulose may be obtained from commercial sources such as ARBOCEL ® A300 or Vitacel EPG 70, each sold by JRS Fibres for Life.
- the powdered cellulose contains the amorphous regions of cellulose present in the natural cellulose before processing. In some examples, the powdered cellulose is not microcrystalline cellulose (MCC).
- the term 'average particle size' when referring to the powdered cellulose indicates the average particle size as measured by laser diffraction, for example according to ASTM D4464-15 applying the Fraunhofer Diffraction theory.
- the average particle size can be measured using suitable equipment such as the Malvern Mastersizer 3000.
- Laser diffraction measures particle size distributions by measuring the angular variation in intensity of light scattered as a laser beam passes through a dispersed particulate sample. Large particles scatter light at small angles relative to the laser beam and small particles scatter light at large angles.
- the angular scattering intensity data is then analysed to calculate the size of the particles responsible for creating the scattering pattern, using the Mie theory of light scattering.
- the particle size is reported as a volume equivalent sphere diameter.
- the term 'average particle size' refers to the Dv50 (or Dv0.5), which is the median for a volume distribution.
- the active agent comprises or consists of a nicotinic compound.
- the nicotinic compound may be added to or mixed with the powdered cellulose prior to incorporation into the smokeless article.
- the cellulose fibres are loaded into a suitable dryer, sprayed with a solution of nicotinic compound and dried to form nicotine-dosed cellulose fibres.
- the dyer may be a fluidised bed dryer.
- the solution may be solution of nicotinic compound in glycerin.
- the solution of nicotinic compound in glycerin may comprise from 10 to 50 wt% nicotinic compound based on the total solution weight, for example from 10 to 40 wt% or from 10 to 30 wt%.
- the nicotinic compound (for example, dissolved in a suitable solvent) may be mixed with the powdered cellulose.
- the powdered cellulose may be added to the solution of nicotinic compound, or added to a mixture containing the nicotinic compound and one or more further components.
- the nicotinic compound may be selected from nicotine, nicotine salt(s), nicotine complex(es); and nicotine solvate(s).
- the nicotinic compound may be present within a plant material such as tobacco.
- the content may comprise or consist of a mixture of powdered cellulose and tobacco.
- the smokeless article is tobacco free.
- the user may experience a similar or enhanced recreational/pharmaceutical effect as compared to conventional tobacco-containing products without experiencing undesirable components inherent to tobacco (e.g. tobacco flavour).
- the content comprises powdered cellulose, a nicotinic compound, and water. In some examples, the content comprises powdered cellulose, a nicotinic compound, water, and a flavourant.
- the content of the smokeless article comprises at least 20 wt% powdered cellulose, for examples at least 25 wt%, at least 35 wt%, at least 40 wt%, or at least 45 wt%, based on the total weight of the content.
- the content of the smokeless article comprises from 25 wt% to 60 wt% powdered cellulose, for example from 20 wt% to 60 wt%, from 20 wt% to 55 wt%, for example from 20 wt% to 50 wt%, for example from 20 wt% to 45 wt%, for example from 25 wt% to 45 wt%, based on the total weight of the content.
- the content of the smokeless article comprises from 40 wt% to 60 wt% powdered cellulose, for example from 40 wt% to 55 wt%, from 40 wt% to 50 wt% or from 40 wt% to 45 wt%, based on the total weight of the content.
- the content comprises nicotinic compound (e.g. nicotine) in an amount of from 0.3 wt% to 1 wt%, for example from 0.4 wt% to 1 wt%, from 0.5 wt% to 1 wt%, from 0.5 wt% to 0.9 wt%, from 0.5 wt% to 0.8 wt%, or from 0.3 wt% to 0.8 wt% based on the total weight of the content.
- nicotinic compound e.g. nicotine
- the total nicotinic compound (e.g. nicotine) content is from 4 to 15 mg. In some examples, the nicotinic compound content is about 10 mg.
- the amount of water in the content is from 30 wt% to 60 wt%, for example from 35 wt% to 60 wt%, from 40 wt% to 60 wt%, from 40 wt% to 55 wt%, from 40 wt% to 50 wt%, or from 45 wt% to 50 wt% based on the total weight of the content. In some examples, the amount of water in the content is from 45 wt% to 48 wt%, based on the total weight of the content.
- the content may comprise powdered cellulose, a nicotinic compound, and at least 45 wt% water, based on the total weight of the content, for example at least 46 wt%, at least 47 wt%, at least 48 wt%, at least 49 wt%, at least 50 wt%, at least 51 wt% or at least 52 wt%.
- Such high water content has not been previously possible without detrimental effects on other properties of the formulation such as powder flow and compressibility.
- the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30.
- the content has a Carr's Index of from 25 to 42, for example 29 to 42, 30 to 42, 30 to 40, 30 to 39 or 33 to 39.
- the content has a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- the content has a Hausner's ratio of from 1.35 to 1.74, for example 1.38 to 1.74, 1.40 to 1.74, 1.40 to 1.70, 1.45 to 1.70, 1.45 to 1.65 or 1.50 to 1.65.
- the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30; and a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- the content has a Carr's Index of less than 40; and a Hausner's ratio of less than 1.65.
- the content has a bulk density above about 0.20 g/mL, for example above about 0.21 g/mL, above about 0.22 g/mL, or above about 0.24 g/mL.
- the content has a bulk density up to about 0.40 g/mL, for example up to about 0.38 g/mL, up to about 0.36 g/mL, up to about 0.34 g/mL, or up to about 0.338 g/mL.
- the content has a bulk density of 0.20-0.40 g/mL, 0.24-0.40 g/mL, 0.24-0.38 g/mL, 0.24-0.36 g/mL, 0.24-0.34 g/mL, or 0.242-0.337 g/mL.
- the content has a tapped density above about 0.35 g/mL, for example above about 0.36 g/mL, above about 0.38 g/mL, or above about 0.39 g/mL.
- the content has a tapped density up to about 0.60 g/mL, for example up to about 0.58 g/mL, up to about 0.56 g/mL, up to about 0.54 g/mL, or up to about 0.51 g/mL.
- the content has a tapped density of 0.35-0.60 g/mL, 0.36-0.58 g/mL, 0.38-0.55 g/mL, 0.38-0.52 g/mL, 0.39-0.51 g/mL, or 0.394-0.505 g/mL.
- the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65 and a bulk density of 0.20-0.40 g/mL. In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65, a bulk density of 0.20-0.40 g/mL and a tapped density of 0.35-0.60 g/mL.
- Tapped density can be measured using the method described in the Examples.
- the content comprises powdered cellulose, a nicotinic compound, and may comprise one or more additional substances.
- the content comprises powdered cellulose, a nicotinic compound, water and may comprise one or more additional substances.
- the or each additional substance may individually be a biologically/pharmacologically active compound, one or more types of cellulose, pH stabilisers or adjusters, humectants, flavourants, fillers, preservatives, aqueous/non-aqueous solvents and binders.
- the or each additional substance may be provided for more than one purpose.
- the contents of the pouch preferably occupies substantially all of the internal volume of the pouch.
- the contents may occupy 80%, 85%, 90%, 95% or 100% of the internal volume of the pouch.
- the contents may comprise a solid material to provide physical integrity, such as an organic material (e.g. plant material) or an inorganic material. Such solid materials may naturally or inherently contain one or more biologically/pharmacologically active compounds and/or additives.
- Biologically/pharmacologically active compounds are provided to produce a pharmacological effect in the user.
- Suitable biologically/pharmacologically active compounds include the group consisting of: nicotine, cocaine, caffeine, opiates and opioids, cathine and cathinone, kavalactones, mysticin, beta-carboline alkaloids, salvinorin A together with any combinations, functional equivalents to, and/or synthetic alternatives of the foregoing.
- Biologically/pharmacologically active compounds may also have additive properties.
- the contents include an active compound comprising nicotine and wherein the form of nicotine is selected from the group consisting of nicotine salts, nicotine base, stabilized nicotine and mixtures thereof.
- the contents may include at least one nicotine salt selected from the group consisting of nicotine hydrochloride, nicotine dihydrochloride, nicotine monotartrate, nicotine ditartrate, nicotine ditartrate dihydrate, nicotine sulfate, nicotine zinc chloride monohydrate, nicotine salicylate and mixtures thereof.
- One or more types of cellulose can be selected from microcrystalline cellulose (MCC), methyl cellulose (MC), ethyl cellulose (EC), hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC) and carboxymethyl cellulose (CMC).
- MCC microcrystalline cellulose
- MC methyl cellulose
- EC ethyl cellulose
- HEC hydroxyethyl cellulose
- HPC hydroxypropyl cellulose
- CMC carboxymethyl cellulose
- the contents comprise the powdered cellulose, a nicotinic compound, and microcrystalline cellulose.
- MCC is particularly effective when it comes to reducing the rate of nicotine release from the pouch during use.
- Suitable MCC for use in the invention includes Avicel ® PH-102 available from DuPont.
- the one or more types of cellulose is microcrystalline cellulose (MCC).
- MCC microcrystalline cellulose
- the term microcrystalline cellulose is a purified, partially depolymerised cellulose prepared by treating ⁇ -cellulose, obtained as a pulp from strains of fibrous plant material. Suitable types of MCC are know to the skilled person.
- the one or more types of cellulose are in the form of particles having a D 50 particle size of at least 30 ⁇ m, for examples at least 40 ⁇ m, at least 50 ⁇ m, at least 60 ⁇ m, at least 70 ⁇ m, at least 80 ⁇ m, at least 90 ⁇ m, at least 100 ⁇ m, at least 110 ⁇ m, at least 120 ⁇ m, at least 130 ⁇ m, at least 140 ⁇ m, at least 150 ⁇ m, at least 160 ⁇ m, at least 170 ⁇ m, or at least 180 ⁇ m.
- the one or more types of cellulose are in the form of particles having a D 50 particle size of up to 500 ⁇ m, for example up to 500 ⁇ m, up to 450 ⁇ m, up to 400 ⁇ m, up to 350 ⁇ m, up to 300 ⁇ m, up to 290 ⁇ m, up to 280 ⁇ m, up to 270 ⁇ m, up to 260 ⁇ m, up to 250 ⁇ m, up to 240 ⁇ m, up to 230 ⁇ m, or up to 220 ⁇ m.
- a D 50 particle size of up to 500 ⁇ m, for example up to 500 ⁇ m, up to 450 ⁇ m, up to 400 ⁇ m, up to 350 ⁇ m, up to 300 ⁇ m, up to 290 ⁇ m, up to 280 ⁇ m, up to 270 ⁇ m, up to 260 ⁇ m, up to 250 ⁇ m, up to 240 ⁇ m, up to 230 ⁇ m, or up to 220 ⁇ m.
- the one or more types of cellulose are in the form of particles having a D 50 particle size of from 30 to 500 ⁇ m, for examples from 100 to 500 ⁇ m or from 150 to 250 ⁇ m. In some embodiments, the one or more types of cellulose are in the form of particles having a D 50 particle size of about 100 ⁇ m. In some embodiment, the cellulose is microcrystalline cellulose type 102 (MCC 102).
- the one or more types of cellulose are in the form of particles having a D 50 particle size of about 200 ⁇ m.
- the content of the smokeless article comprises from 0 to 40 wt% one or more types of cellulose, for examples from 0 to 35 wt%, from 0 to 30 wt%, from 0 to 25 wt%, from 0 to 20 wt%, from 5 to 30 wt%, from 5 to 25 wt%, from 5 to 20 wt %, or from 10 to 20 wt% based on the total weight of the content.
- the content of the smokeless article comprises at least 5 wt% one or more types of cellulose, for examples at least 10 wt%, at least 15 wt%, at least 20 wt% based on the total weight of the content.
- pH stabilisers or adjusters may be provided to adjust the user experience and/or modify the bicavailability of a pharmacologically active compound. For instance, under acidic conditions, nicotine is protonated and does not readily cross mucous membranes.
- suitable pH stabilisers include ammonia, ammonium carbonate, sodium carbonate and calcium carbonate.
- the overall pH of the smokeless article is preferably pH 7 to pH 9, such as pH 7.25 to pH 8.75 or pH 7.5 to pH 8.5.
- the overall pH of a smokeless article may be determined by, for example, (i) placing the smokeless article in 10 mL of distilled water (ii) agitating the mixture for at least 5 minutes and (iii) measuring the pH of the solution with a pH probe.
- the content comprises a pH modifier (e.g. sodium carbonate) in an amount of from 0 wt% to 1 wt%, for example from 0.01 wt% to 1 wt%, from 0.01 wt% to 0.5 wt%, from 0.01 wt% to 0.2 wt%, from 0.01 wt% to 0.1 wt%, from 0.01 wt% to 0.08 wt%, or from 0.01 wt% to 0.06 wt% based on the total weight of the content.
- a pH modifier e.g. sodium carbonate
- the pH modifier may have a lower limit of at least 0.01 % by weight of the contents such as at least 0.02 wt%, such as at least 0.03 wt%, such as at least 0.04 wt%, such as at least 0.05 wt%, or such as least 0.06 wt%.
- Fillers may be provided to increase the volume of the smokeless article (e.g. by increasing the volume contained within the pouch and to strengthen the contents).
- Suitable fillers include calcium carbonate, calcium phosphate, corn starch, grains, lactose, polysaccharides (e.g. maltodextrin), polyols, sugars (e.g. dextrose, manitol, xylitol, sorbitol), natural fibres (e.g. non-tobacco fibres), microcrystalline cellulose, cellulose and cellulose derivatives (e.g. finely divided cellulose), lignocellulose fibres (e.g. wood fibres), jute fibres and combinations thereof.
- the filler content is 5 to 10 wt% of the contents e.g. around 6 to 9 wt%.
- Flavourants may be provided in solid or liquid form. Suitable flavourants include coffee, eucalyptus, menthol, liquorice, peppermint, spearmint, chocolate, fruit flavour (including e.g. citrus, cherry etc.), vanilla, spice (e.g. ginger, cinnamon) and tobacco flavour.
- the flavourant may be evenly dispersed throughout the contents or may be provided in isolated locations and/or varying concentrations throughout the contents.
- flavourant denotes a compound having a desirable taste, aroma or both.
- the content comprises one or more flavourants (e.g. peppermint flavour) in an amount of from 0 wt% to 10 wt%, for example from 1 wt% to 10 wt%, from 1 wt% to 8 wt%, from 1 wt% to 6 wt%, or from 2 wt% to 6 wt% based on the total weight of the content.
- flavourants e.g. peppermint flavour
- Humectants may be provided to control moisture content thereby preventing the smokeless article from drying out during storage and reducing the amount of saliva wetting required before the user experience begins.
- Suitable humectants include polyhydric alcohols (e.g. propylene glycol (PG), triethylene glycol, 1 ,2-butane diol and vegetable glycerine (VG)) and their esters (e.g. glycerol mono-, di- or tri-acetate).
- the humectant may have a lower limit of at least 1 % by weight of the contents such as at least 2 wt%, such as at least 5 wt%, such as at least 10 wt%, such as at least 20 wt%, such as at least 30 wt%, or such as least 40 wt%.
- the humectant may have an upper limit of at most 50% by weight of the contents, such as at most 40 wt%, such as at most 30 wt%, or such as at most 20 wt%, such as at most 10 wt %, such as at most 5 wt %, such as at most 2 wt%.
- the amount of humectant is 1 to 40 wt% of the contents, such as 2 to 20 wt% or 5 to 10 wt%.
- Smokeless articles having a total moisture content of 10% or less are generally considered to be 'dry'.
- Smokeless articles having a total moisture content of 40% or more are generally considered to be ⁇ wet'.
- Sweeteners may be provided to modify the user taste perception and, in particular, overcome bitter flavours that result from other substances. Suitable sweeteners include honey, sugar, brown sugar, glucose, fructose, sucrose, aspartame, xylitol, maltitol, saccharin sodium, glycyrrhizin tripotassium liquorice, jujube or a mixture thereof.
- the content comprises a sweetener (e.g. acesulfame K) in an amount of from 0 wt% to 1 wt%, for example from 0.01 wt% to 1 wt%, from 0.01 wt% to 0.5 wt%, from 0.01 wt% to 0.2 wt%, from 0.01 wt% to 0.1 wt%, or from 0.01 wt% to 0.08 wt% based on the total weight of the content.
- a sweetener e.g. acesulfame K
- the sweetener may have a lower limit of at least 0.01 % by weight of the contents such as at least 0.02 wt%, such as at least 0.03 wt%, such as at least 0.04 wt%, such as at least 0.05 wt%, or such as least 0.06 wt%.
- Stabilisers are provided to prevent decomposition or degradation over time during storage by, for example, retarding oxidation or unwanted biological activity.
- Stabilisers may be selected from the group consisting of antioxidants including vitamin E, such as tocopherole, ascorbic acid, sodium pyrosulfite,
- butylhydroxytoluene butylated hydroxyanisole, edetic acid and salts thereof; and preservatives including citric acid, tartaric acid, lactic acid, malic acid, acetic acid, benzoic acid, sorbic acid and salts thereof.
- Binders may be provided. Suitable binders include starches and/or cellulosic binders such as methyl cellulose, ethyl cellulose, hydroxypropyl! cellulose, hydroxyethyl cellulose and carboxymethyl cellulose, gums such as xanthan, guar, arabic and/or locust bean gum, organic acids and their salts such as alginic acid (sodium alginate), agar and pectins. In some embodiments the binder content is 5 to 10 wt% of the contents, e.g. around 6 to 9 wt% or 7 to 8 wt%.
- Colourants may be provided to modify the user impression of the smokeless article. Colourants include whitening agents. Colourants may be selected from one or more of common colourants such as curcumin (E100), turmeric (E100(ii)), riboflavin (E101), riboflavin-5'-phosphate (E101(ii)), tartrazine (E102), quinoline yellow (E104), riboflavin-5-sodium phosphate (E106), yellow 2G (E107), sunset yellow FCF (E110), carmine, cochineal (E120), azorubine (E122), amaranth (E123), ponceau 4R (E124), erythrosine (E127), red 2G (E128), allura red AC (E129), patent blue V (E131), indigotine (E132), brilliant blue FCF (E133) chlorophylls (E140), copper complexes of chlorophyll (E141), green S (E142), caramel (E150a-d), brilliant black BN (E
- Plant material may be provided for physical integrity and may function as a natural source of substances such as, for example, biologically/pharmacologically active compounds, flavourants, pH stabilisers etc.
- the plant material may comprise least one plant material selected from the list including Amaranthus dubius, Arctostaphylos uva-ursi (Bearberry), Argemone mexicana, Amica, Artemisia vulgaris, Yellow Tees, Galea zacatechichi, Canavalia maritima (Baybean), Cecropia mexicana (Guamura), Cestrum noctumum, Cynoglossum virginianum (wild comfrey), Cytisus scoparius, Damiana, Entada rheedii, Eschscholzia califomica (California Poppy), Fittonia albivenis, Hippobroma longiflora, Humulus japonica (Japanese Hops), Humulus lup
- the plant material comprises or consist of one or more of wheat fibres, cellulose fibres, bamboo fibres, pine fibres and eucalyptus fibres.
- the plant material is bamboo fibres.
- the bamboo fibres may have a particle size of 10-500 ⁇ m, for example 10-450 ⁇ m, 10-400 ⁇ m, 10-350 ⁇ m, 10-300 ⁇ m, 10-250 ⁇ m, 10-200 ⁇ m, 10-150 ⁇ m, 10-100 ⁇ m, 10-50 ⁇ m, 15-50 ⁇ m, 10-450 ⁇ m, 15-45 ⁇ m, 20-50 ⁇ m, 20-45 ⁇ m, 20-40 ⁇ m, or 25-35 ⁇ m.
- the bamboo fibres have a particle size of about 30 ⁇ m.
- the bamboo fibres have a particle size of 15-500 ⁇ m, for example, 20-500 ⁇ m, 50-500 ⁇ m, 100-500 ⁇ m, 150-500 ⁇ m, 200-500 ⁇ m, 250-500 ⁇ m, 250-450 ⁇ m, 250-400 ⁇ m, 250-350 ⁇ m, 260-340 ⁇ m, 270-330 ⁇ m, 280-320 ⁇ m, 290-310 ⁇ m, or 295-305 ⁇ m. In some embodiments, the bamboo fibres have a particle size of about 300 ⁇ m.
- the bamboo fibres have a particle size of 30-300 ⁇ m.
- the bamboo fibres are nicotine-dosed bamboo fibres.
- the nicotine-dosed bamboo fibres comprise a nicotinic compound selected from nicotine, nicotine salts(s), nicotine complex(es), and nicotine solvate(s).
- the nicotinic compound is provided in a plant material.
- the plant material is tobacco.
- particle size when referring to fibres such as bamboo fibres indicates the maximum size of the longest dimension of the fibres. For example, a particle size of 50 ⁇ m indicates that in the population of fibres, the maximum fibre length is 50 ⁇ m.
- Particles having the desired particle size may be obtained by passing a population of fibres through a sieve of corresponding mesh size. For example, to obtain fibres of particle size 300 ⁇ m (i.e. a maximum fibre length of 300 ⁇ m), a population of fibres are passed through a sieve with 300 ⁇ m diameter apertures in the mesh. In this way, fibres with a length of 300 ⁇ m or less pass through the mesh and fibres longer than 300 ⁇ m are retained by the mesh. The fibres which pass through the mesh may then be used in the smokeless article of the invention, having a particle size of 300 ⁇ m. Fibres of a desired particle size are also available from commercial suppliers such as Jelu-technik.
- the term "bamboo fibres" refers to natural fibres from plants of the Bambusoideae subfamily of the Poaceae family of grasses.
- the fibres may originate from any part of the plant, but in some embodiments may be originate from the stem of the plant.
- the fibres may be obtained from commercial sources such as JELUCEL ® BF fibres sold by Jelu-technik, or may be prepared by grinding or milling plant material until fibers of the required particle size are obtained.
- the term "nicotine-dosed bamboo fibres” refers to a composition comprising bamboo fibres and a nicotinic compound.
- the nicotinic compound may be added to or mixed with the bamboo fibres prior to incorporation into the smokeless article.
- the bamboo fibres are loaded into a suitable dryer, sprayed with a solution of nicotinic compound and dried to form nicotine-dosed bamboo fibres.
- the dryer may be a fluidised bed dryer.
- the solution may be a solution of nicotinic compound in glycerin.
- the solution of nicotinic compound in glycerin may comprise from 10 to 50 wt% nicotinic compound based on the total solution weight, for example from 10 to 40 wt% or from 10 to 30 wt%.
- any suitable parts of the tobacco plant may be used. This includes leaves, stems, roots, bark, seeds and flowers.
- the tobacco may comprise one or more of leaf tobacco, stem tobacco, tobacco powder, tobacco dust, tobacco derivatives, expanded tobacco, homogenised tobacco, shredded tobacco, extruded tobacco, cut rag tobacco and/or reconstituted tobacco (e.g. slurry recon or paper recon).
- the contents may comprise at least 50 wt% plant material based on the weight of the contents, e.g. at least 60 wt% plant material e.g. around 65 wt% plant material.
- the contents may comprise 80 wt% or less plant material e.g. 75 or 70 wt% or less plant material.
- the contents may comprise a gathered sheet of homogenised (e.g. paper/slurry recon) tobacco or gathered shreds/strips formed from such a sheet.
- homogenised e.g. paper/slurry recon
- the sheet may have a grammage greater than or equal to 100 g/m 2 , e.g. greater than or equal to 110 g/m 2 such as greater than or equal to 120 g/m 2 .
- the sheet may have a grammage of less than or equal to 300 g/m 2 e.g. less than or equal to 250 g/m 2 or less than or equal to 200 g/m 2 .
- the sheet may have a grammage of between 120 and 190 g/m 2 .
- the content comprises or consists of:
- the content comprises or consists of:
- the content comprises or consists of:
- a second aspect of the invention is the use of powdered cellulose having an average particle size of 100-500 ⁇ m in a smokeless article, to improve powder flow, improve mouth feel, and/or improve nicotine perception.
- a third aspect of the invention is a process of manufacturing the smokeless article according to the first aspect, comprising the steps of:
- a fourth of the invention is a kit comprising a plurality of smokeless articles according to the first aspect and a container.
- a fifth aspect of the invention is a smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and an active agent and/or flavourant; wherein the content satisfies one or more of the following:
- the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30.
- the content has a Carr's Index of from 25 to 42, for example 29 to 42, 30 to 42, 30 to 40, 30 to 39 or 33 to 39.
- the content has a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- the content has a Hausner's ratio of from 1.35 to 1.74, for example 1.38 to 1.74, 1.40 to 1.74, 1.40 to 1.70, 1.45 to 1.70, 1.45 to 1.65 or 1.50 to 1.65.
- the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30; and a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- the content has a Carr's Index of less than 40; and a Hausner's ratio of less than 1.65.
- the content has a bulk density above about 0.20 g/mL, for example above about 0.21 g/mL, above about 0.22 g/mL, or above about 0.24 g/mL.
- the content has a bulk density up to about 0.40 g/mL, for example up to about 0.38 g/mL, up to about 0.36 g/mL, up to about 0.34 g/mL, or up to about 0.338 g/mL.
- the content has a bulk density of 0.20-0.40 g/mL, 0.24-0.40 g/mL, 0.24-0.38 g/mL, 0.24-0.36 g/mL, 0.24-0.34 g/mL, or 0.242-0.337 g/mL.
- the content has a tapped density above about 0.35 g/mL, for example above about 0.36 g/mL, above about 0.38 g/mL, or above about 0.39 g/mL.
- the content has a tapped density up to about 0.60 g/mL, for example up to about 0.58 g/mL, up to about 0.56 g/mL, up to about 0.54 g/mL, or up to about 0.51 g/mL.
- the content has a tapped density of 0.35-0.60 g/mL, 0.36-0.58 g/mL, 0.38-0.55 g/mL, 0.38-0.52 g/mL, 0.39-0.51 g/mL, or 0.394-0.505 g/mL.
- the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65 and a bulk density of 0.20-0.40 g/mL. In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65, a bulk density of 0.20-0.40 g/mL and a tapped density of 0.35-0.60 g/mL.
- Tapped density can be measured using the method described in the Examples.
- a first embodiment of a smokeless article 10 having a pouch 12 containing contents 14.
- the pouch 12 is substantially rectangular.
- the pouch 12 is formed from a single sheet of material and is substantially filled by the contents 14.
- the pouch 12 has a seal 16 along each of the three edges where the inner face of the single sheet meets itself to seal the contents 14 in the pouch 12.
- Figure 2 shows a second embodiment of a smokeless article 10' having a pouch 12 containing contents 14.
- the pouch 12 is substantially circular.
- the pouch 12 is formed from two opposing sheets of material and is substantially filled by the contents 14.
- the pouch has a circumferential seal 16 along the edges where the two opposing sheets of material meet to seal the contents 14 in the pouch 12.
- Figure 3 shows a third embodiment of a smokeless article 10" that, like the first embodiment, has a pouch 12 made from a single sheet of material. However, one of the three seals 16' is formed by an overlap of the inner face and the outer face of the single sheet meet to seal the contents 14 in the pouch 12. The remaining two seals at opposing ends of the pouch 12 are formed where the inner face of the single sheet meets itself.
- Figure 4 shows a fourth embodiment of a smokeless article 10'" that comprises the third embodiment enclosed by outer pouch 12" having an outer contents 14" positioned in the space between the inner pouch 12' and the outer pouch 12".
- the outer pouch 12" also has a circumferential seal 16'" to seal the outer contents 14" and inner pouch 12' in the outer pouch 12".
- Use of the second embodiment begins when the smokeless article 10'" is placed in the user's mouth where it is exposed to saliva. Saliva first permeates outer pouch 12" and dissolves and extracts the saliva soluble substances of outer contents 14". Upon leaving the outer pouch 12", the saliva soluble substances of outer contents 14" therefore provide the user with a first experience. Saliva subsequently further permeates the inner pouch 12' where it dissolves and extracts the saliva soluble substances of inner contents 14'. The saliva soluble substances of inner contents 14' therefore provide the user with a complimentary and secondary experience. When the extractable amount of saliva soluble substances in the inner contents 14' and outer contents 14" drops below perceivable levels the active lifetime of the smokeless article 10'" has ended.
- Figure 5 shows that there is a negative correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the Hausner's Ratio of the content. In other words, as the percentage of powdered cellulose is increased, the flowability of the content is improved.
- Figure 6 shows that there is a negative correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the Carr's Index of the content. In other words, as the percentage of powdered cellulose is increased, the compressibility of the content is improved.
- Figure 7 shows that there is a positive correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the density (both bulk and tapped) of the content. In other words, as the percentage of powdered cellulose is increased, the compressibility of the content is improved.
- Example 1 was prepared containing powdered cellulose with an average particle size of 320 ⁇ m (ARBOCEL ® A300).
- Example 1 contained the following components: Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 21.90 131.84 32.85 Arbocel A300 Bulking Agent (Snus Substitute) 21.90 131.84 32.85 Peppermint flavour Flavour Extract 4.00 24.08 6.00 Total 100.00 602.01 150.00
- Arbocel A300 is powdered cellulose supplied by Pharma Excipients.
- BF-300 is JELUCEL ® BF-300 bamboo fibres supplied by Jelu-technik.
- Example 2 was prepared containing powdered cellulose with an average particle size of 320 ⁇ m (ARBOCEL ® A300).
- Example 2 contained the following components: Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 0.00 0.00 0.00 0.00 Arbocel A300 Bulking Agent (Snus Substitute) 43.80 263.68 65.70 Peppermint flavour Flavour Extract 4.00 24.08 6.00 Total 100.00 602.01 150.00
- Comparative Example 1 was prepared containing no powdered cellulose (only bamboo fibres were used as bulking agent). Comparative Example 1 contained the following components: Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 43.80 263.68 65.70 Arbocel A300 Bulking Agent (Snus Substitute) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
- Example 1 The compositions of Example 1, Example 2, and Comparative Example 1 were each prepared using the following method (Protocol A):
- Comparative Example 1 ⁇ 0.151 0.265 42.8 1.75 ⁇ Prepared at lab-scale following the method of Protocol A
- the Hausner's ratio of Examples 1 and 2 and Comparative Example 1 are plotted in Figure 5 .
- powdered cellulose in particular powdered cellulose having an average particle size of 100-500 ⁇ m, e.g. about 320 ⁇ m, as a bulking agent instead of other plant-based fillers such as bamboo fibres improves the powder properties.
- the Carr's Index of Examples 1 and 2 and Comparative Example 1 are plotted in Figure 6 .
- % powdered cellulose as a proportion of the total amount of powdered cellulose and bamboo fibres increases.
- powdered cellulose in particular powdered cellulose having an average particle size of 100-500 ⁇ m, e.g. about 320 ⁇ m, as a bulking agent instead of other plant-based fillers such as bamboo fibres improves the powder properties.
- the Carr's Index and Hausner's Ratio would decrease further when moving the production from lab-scale to factory scale. More specifically, the Carr's index can be expected to decrease by ⁇ 11 % and the Hausner's Ratio can be expected to decrease by ⁇ 8 %.
- Example 2 when Example 2 is prepared on a factory scale the Carr's Index and Hausner's Ratio could be expected to be further improved to around 29.7 and 1.38 respectively.
- Another important aspect associated with the use of powdered cellulose is the increase in density. This means that during manufacture of the product, the feedstock occupies a smaller volume, and a larger mass of fibres may be processed per unit time. This increases manufacturing capacity, reducing the overall production cost for the product and increasing efficiency of the manufacturing process.
- the higher density means that the pouch may be smaller while carrying the same mass of fibre. This means that the amount of material used to manufacture the pouch per smokeless article is reduces, which reduces manufacturing cost.
- the use of powdered cellulose improved the mouth feel of the smokeless article compared to products that do not contain powdered cellulose.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A smokeless article is described including a pouch enclosing a content. The content contains powdered cellulose and an active agent and/or flavourant, wherein the powdered cellulose has an average particle size of 100-500 µm. The smokeless article may be used for oral delivery of active agent and/or flavourant to a user. Methods of manufacturing the article, kits and uses are also described.
Description
- The present disclosure relates to a smokeless article. In particular, the disclosure relates to a smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and a nicotinic compound, wherein the powdered cellulose has an average particle size of 100-500 µm. The disclosure also relates to the use of a content, the content comprising powdered cellulose and a nicotinic compound.
- Smokeless articles are a suitable alternative to conventional cigarettes because they do not require heating for substance delivery to the user. Instead, smokeless articles rely on saliva to extract soluble substances, typically nicotine and/or flavours, from tobacco contained within the smokeless article.
- Smokeless articles are placed in the mouth where saliva extracts the soluble element from the content contained within. Typically, the smokeless article is placed in the oral cavity, sublingually or in the oral vestibule (between the teeth and lips/cheeks). The user may assist extraction by oral manipulation, such as by chewing and/or sucking or pressing on the outside of the mouth to squeeze the pouch.
- The above-described extraction and delivery process continues until the soluble element is depleted from the smokeless article. The smokeless article is then removed from the mouth and disposed of.
- Some commercially available smokeless articles contain snuff. Snuff is smokeless tobacco made from ground or pulverised tobacco leaves. Snuff is available in dry form or wet (moist) form. Moist snuff may be referred to as snus. Two common varieties of snus are Scandinavian snus and American snus. Both varieties of snus are available in a loose form, but are often contained within a saliva permeable pouch.
- There is a need for improved design of smokeless articles to enhance the user experience and improve the function of its constituent components.
- The present disclosure has been devised in the light of the above considerations.
- At its most general, the present disclosure relates to a smokeless article e.g. an oral nicotine delivery (OND) article for oral use.
- The present disclosure provides in a first aspect a smokeless article for oral consumption comprising a pouch enclosing a content.
- In some examples, the content comprises powdered cellulose and an active agent and/or flavourant, wherein the powdered cellulose has an average particle size of 100-500 µm.
- A smokeless article comprising powdered cellulose of a particle size within this range leads to improved properties of the content and the article itself. The resultant content has a lower Carr's Index (indicating improved compressibility) and a lower Hausner's Ratio (indicating improved flowability) than contents prepared with powdered cellulose having an average particle size outside this range.
- The improved flowability and/or compressibility of the content is itself advantageous because it improves the handling of the powder during manufacture.
- In addition, since the powder has improved compressibility and/or flowability, it is possible to increase the amount of water in the content beyond what would normally be possible, while still maintaining acceptable compressibility and flowability. As a result, when a higher water content is used, the user's perception of the active agent and/or flavourant can be improved, because a higher water content causes the perceived active agent content or flavourant content of the smokeless article to be increased. The end result is a smokeless article which seems "stronger" to the user, which is desirable to many users.
- Aside from this, the powdered cellulose within this particle size range improves the mouth feel of the smokeless article which has a positive impact on the consumer's experience.
- The presence of powdered cellulose with an average particle size of 100-500 µm therefore delivers a smokeless article which is easier to manufacture due to improved compressibility and/or flowability of the constituent content, which may deliver a more intense experience to the user, and which also improves mouth feel.
- As used herein, the term "oral consumption" is intended to refer to any oral administration route achieved by placing the smokeless article into the oral cavity. This includes, but is not limited to, buccal, sub-lingual, periodontal, gingival and ingestion.
- The smokeless article may be an oral nicotine delivery (OND) article when the active agent within the content comprises a nicotinic compound.
- In some examples, the active agent comprises or consists of an active compound. In some examples the active agent comprises or consists of a nicotinic compound.
- The smokeless article comprises a pouch enclosing a content, wherein the content (including e.g. a nicotinic compound and non-tobacco plant material fibres) is completely enclosed by the pouch. The pouch is sealed to ensure that the contents of the pouch does not scatter inside the mouth.
- The smokeless article may have a mass of about 0.1 g to 5.0 g, such as about 0.5 g to about 4.0 g or about 1.0 g to about 3.0 g.
- The smokeless article may have a length of about 30 mm, such as about 28 mm or 26 mm, a width of about 12 mm, such as about 10 mm or 8 mm, and a depth of about 5 mm, such as about 4 mm or 3 mm.
- The smokeless article may have an active lifetime of about 20 minutes to about 60 minutes, such as about 25 minutes to 50 minutes or about 30 minutes to about 45 minutes, after being placed in the mouth. As used herein, the term "active lifetime" is intended to refer to the amount of time after being placed in the mouth that the smokeless article provides the user with a perceptible taste and/or physiological experience. For example, for an article containing an active ingredient such as nicotine or other pharmacologically active ingredient the active lifetime may be defined as the in use period of time in which 90%wt of the available pharmacologically active is released. In other words, the active lifetime may be the duration of time from insertion into the oral cavity for 90%wt of the total amount of nicotine pharmacologically active ingredient that is capable of being released during normal use to dissolve into the user's saliva and /or enter the user's bloodstream. It will therefore be appreciated that the active lifetime of a product may vary from user to user and for a user based on oral conditions, in particular extent of salivation. Nonetheless, the skilled person is able to mimic oral conditions to determine the active lifetime in one instance, which can be used as a comparison or analysis point.
- The pouch may be formed from one or more materials. The pouch material may be formed from fiber, paper, cloth and fabric. The pouch material may be formed from one or more polymeric materials. The polymeric material may be selected from one or more of hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol (PVOH), polyvinylpyrrolidone (PVP), polyethylene oxide (PEO) hydroxyethyl cellulose (HEC), polyethylene glycol (PEG), pullulan, sodium alginate, xanthan gum, tragancanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, maltodextrin, methylmethacrylate copolymer, carboxyvinyl copolymers, starch and gelatin.
- The pouch is typically completely insoluble in saliva. Suitable insoluble pouch materials include, but are not limited to, fiber, paper, water-insoluble polymers, cloth and fabric. Suitable soluble pouch materials include, but are not limited to, water-soluble polymers such as polyethylene oxide (PEO), hydroxypropyl cellulose (HPC) and hydroxypropyl methylcellulose (HPMC).
- The pouch may be formed by, for example, folding a single sheet on itself or bringing two or more sheets together and sealing the edges. The edges may initially be partially sealed to provide an open pouch in which the content (e.g. a nicotinic compound and non-tobacco plant material fibres) may be placed before completely sealing the pouch closed. The sheets may be the same thickness or different thicknesses.
- The pouch is porous. In some examples, at least 50% of the pores have a diameter of 50 µm to 200 µm, such as 100 µm to 175 µm or 125 µm or 150 µm. In some examples, at least 50% of the pores have a diameter of at least 100 µm. For example, in some examples at least 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% of the pores have such diameters.
- The pouch may be coloured or include markings, such as brand logos and text, to improve user perception. The pouch may be partially or completely coloured by a colourant.
- In some examples, the powdered cellulose has an average particle size above 200 µm, for example above 250 µm, above 280 µm, above 290 µm, above 300 µm, or above 310 µm.
- In some examples, the powdered cellulose has an average particle size of up to 450 µm, for example up to 400 µm, up to 350 µm, up to 340 µm, up to 330 µm, or up to 320 µm.
- In some examples, the powdered cellulose has an average particle size of 150-500 µm, for example 200-500 µm, 250-500 µm, 300-500 µm, 300-450 µm, 300-400 µm, or 300-350 µm.
- In some examples, the powdered cellulose has an average particle size of 250-450 µm.
- In some examples, the powdered cellulose has an average particle size of about 320 µm.
- In some examples, the powdered cellulose has a bulk density above about 0.20 g/mL, for example above about 0.25 g/mL, above about 0.28 g/mL, or above about 0.30 g/mL.
- In some examples, the powdered cellulose has a bulk density up to about 0.48 g/mL, for example up to about 0.46 g/mL, up to about 0.44 g/mL, up to about 0.43 g/mL, or up to about 0.42 g/mL.
- In some examples the powdered cellulose has a bulk density of 0.20-0.5 g/mL, 0.25-0.5 g/mL, 0.28-0.5 g/mL, 0.30-0.5 g/mL, 0.30-0.45 g/mL, or 0.30-0.42 g/mL.
- In some examples, the powdered cellulose has a bulk density of 0.30-0.45 g/mL, for example 0.30-0.40 g/mL.
- In some examples, the powdered cellulose has a bulk density of about 0.35 g/mL.
- The bulk density may be determined according to the method in
DIN EN ISO 60. - In some examples, the powdered cellulose has an average particle size of 150-500 µm and a bulk density of 0.20-0.5 g/mL, for example an average particle size of 200-500 µm and a bulk density of 0.25-0.5 g/mL, an average particle size of 250-500 µm and a bulk density of 0.25-0.5 g/mL, or an average particle size of 250-500 µm and a bulk density of 0.28-0.5 g/mL.
- In some examples, the powdered cellulose has an average particle size of 250-450 µm and a bulk density of 0.30-0.45 g/mL. In some examples, the powdered cellulose has an average particle size of 250-350 µm and a bulk density of 0.30-0.40 g/mL.
- In some examples, the powdered cellulose has an average particle size of about 320 µm and a bulk density of about 0.35 g/mL.
- In some examples, the powdered cellulose has an angle of repose of at least 30°, for example at least 32°, at least 34° or at least 36°. In some examples, the powdered cellulose has an angle of repose of up to 48°, for example up to 46°, up to 44°, up to 42°, up to 40°, up to 38° or up to 36°. In some examples, the powdered cellulose has an angle of repose of from 30° to 48°, for example from 30° to 44°, from 30° to 40°, from 32° to 40° or from 34° to 38. Angle of repose is a measure of powder flowability and may be determined by the method in ISO 4324.
- As used herein, the term 'powdered cellulose' refers to a plant-based functional filler. In some examples, the powdered cellulose comprises a mechanically-processed cellulose derivative with a fibrous structure. In some examples, the mechanically processed cellulose derivative is purified. In some examples, the powdered cellulose is mechanically-disintegrated cellulose prepared by processing α-cellulose. In some examples, the powdered cellulose comprises a purified mechanically processed cellulose derivative with a fibrous structure, which is prepared by processing α-cellulose. The powdered cellulose may be obtained from commercial sources such as ARBOCEL ® A300 or
Vitacel EPG 70, each sold by JRS Fibres for Life. - In some examples, the powdered cellulose contains the amorphous regions of cellulose present in the natural cellulose before processing. In some examples, the powdered cellulose is not microcrystalline cellulose (MCC).
- As used herein, the term 'average particle size' when referring to the powdered cellulose indicates the average particle size as measured by laser diffraction, for example according to ASTM D4464-15 applying the Fraunhofer Diffraction theory. The average particle size can be measured using suitable equipment such as the Malvern Mastersizer 3000. Laser diffraction measures particle size distributions by measuring the angular variation in intensity of light scattered as a laser beam passes through a dispersed particulate sample. Large particles scatter light at small angles relative to the laser beam and small particles scatter light at large angles. The angular scattering intensity data is then analysed to calculate the size of the particles responsible for creating the scattering pattern, using the Mie theory of light scattering. The particle size is reported as a volume equivalent sphere diameter.
- The term 'average particle size' refers to the Dv50 (or Dv0.5), which is the median for a volume distribution.
- In some examples the active agent comprises or consists of a nicotinic compound.
- The nicotinic compound may be added to or mixed with the powdered cellulose prior to incorporation into the smokeless article. In some embodiments, the cellulose fibres are loaded into a suitable dryer, sprayed with a solution of nicotinic compound and dried to form nicotine-dosed cellulose fibres. The dyer may be a fluidised bed dryer. The solution may be solution of nicotinic compound in glycerin. In some embodiments, the solution of nicotinic compound in glycerin may comprise from 10 to 50 wt% nicotinic compound based on the total solution weight, for example from 10 to 40 wt% or from 10 to 30 wt%.
- Alternatively, the nicotinic compound (for example, dissolved in a suitable solvent) may be mixed with the powdered cellulose. For example, the powdered cellulose may be added to the solution of nicotinic compound, or added to a mixture containing the nicotinic compound and one or more further components.
- The nicotinic compound may be selected from nicotine, nicotine salt(s), nicotine complex(es); and nicotine solvate(s). Alternatively or additionally, the nicotinic compound may be present within a plant material such as tobacco. Thus, the content may comprise or consist of a mixture of powdered cellulose and tobacco.
- In some examples, the smokeless article is tobacco free. In this way, the user may experience a similar or enhanced recreational/pharmaceutical effect as compared to conventional tobacco-containing products without experiencing undesirable components inherent to tobacco (e.g. tobacco flavour).
- In some examples, the content comprises powdered cellulose, a nicotinic compound, and water. In some examples, the content comprises powdered cellulose, a nicotinic compound, water, and a flavourant.
- In some examples, the content of the smokeless article comprises at least 20 wt% powdered cellulose, for examples at least 25 wt%, at least 35 wt%, at least 40 wt%, or at least 45 wt%, based on the total weight of the content.
- In some examples, the content of the smokeless article comprises from 25 wt% to 60 wt% powdered cellulose, for example from 20 wt% to 60 wt%, from 20 wt% to 55 wt%, for example from 20 wt% to 50 wt%, for example from 20 wt% to 45 wt%, for example from 25 wt% to 45 wt%, based on the total weight of the content.
- In some examples, the content of the smokeless article comprises from 40 wt% to 60 wt% powdered cellulose, for example from 40 wt% to 55 wt%, from 40 wt% to 50 wt% or from 40 wt% to 45 wt%, based on the total weight of the content.
- In some examples, the content comprises nicotinic compound (e.g. nicotine) in an amount of from 0.3 wt% to 1 wt%, for example from 0.4 wt% to 1 wt%, from 0.5 wt% to 1 wt%, from 0.5 wt% to 0.9 wt%, from 0.5 wt% to 0.8 wt%, or from 0.3 wt% to 0.8 wt% based on the total weight of the content.
- In some examples, the total nicotinic compound (e.g. nicotine) content is from 4 to 15 mg. In some examples, the nicotinic compound content is about 10 mg.
- In some examples, the amount of water in the content is from 30 wt% to 60 wt%, for example from 35 wt% to 60 wt%, from 40 wt% to 60 wt%, from 40 wt% to 55 wt%, from 40 wt% to 50 wt%, or from 45 wt% to 50 wt% based on the total weight of the content. In some examples, the amount of water in the content is from 45 wt% to 48 wt%, based on the total weight of the content.
- As explained above, the use of powdered cellulose with an average particle size of 100-500 µm allows the amount of water in the content to be increased without detrimentally impacting powder flow or compressibility, thereby improving nicotine perception for the user. The content may comprise powdered cellulose, a nicotinic compound, and at least 45 wt% water, based on the total weight of the content, for example at least 46 wt%, at least 47 wt%, at least 48 wt%, at least 49 wt%, at least 50 wt%, at least 51 wt% or at least 52 wt%. Such high water content has not been previously possible without detrimental effects on other properties of the formulation such as powder flow and compressibility.
- In some examples, the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30.
- In some examples, the content has a Carr's Index of from 25 to 42, for example 29 to 42, 30 to 42, 30 to 40, 30 to 39 or 33 to 39.
-
- In some examples, the content has a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- In some examples, the content has a Hausner's ratio of from 1.35 to 1.74, for example 1.38 to 1.74, 1.40 to 1.74, 1.40 to 1.70, 1.45 to 1.70, 1.45 to 1.65 or 1.50 to 1.65.
-
- In some examples, the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30; and a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35. In some examples, the content has a Carr's Index of less than 40; and a Hausner's ratio of less than 1.65.
- In some examples, the content has a bulk density above about 0.20 g/mL, for example above about 0.21 g/mL, above about 0.22 g/mL, or above about 0.24 g/mL.
- In some examples, the content has a bulk density up to about 0.40 g/mL, for example up to about 0.38 g/mL, up to about 0.36 g/mL, up to about 0.34 g/mL, or up to about 0.338 g/mL.
- In some examples the content has a bulk density of 0.20-0.40 g/mL, 0.24-0.40 g/mL, 0.24-0.38 g/mL, 0.24-0.36 g/mL, 0.24-0.34 g/mL, or 0.242-0.337 g/mL.
- In some examples, the content has a tapped density above about 0.35 g/mL, for example above about 0.36 g/mL, above about 0.38 g/mL, or above about 0.39 g/mL.
- In some examples, the content has a tapped density up to about 0.60 g/mL, for example up to about 0.58 g/mL, up to about 0.56 g/mL, up to about 0.54 g/mL, or up to about 0.51 g/mL.
- In some examples the content has a tapped density of 0.35-0.60 g/mL, 0.36-0.58 g/mL, 0.38-0.55 g/mL, 0.38-0.52 g/mL, 0.39-0.51 g/mL, or 0.394-0.505 g/mL.
- In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65 and a bulk density of 0.20-0.40 g/mL. In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65, a bulk density of 0.20-0.40 g/mL and a tapped density of 0.35-0.60 g/mL.
- Tapped density can be measured using the method described in the Examples.
- In some examples, the content comprises powdered cellulose, a nicotinic compound, and may comprise one or more additional substances.
- In some examples, the content comprises powdered cellulose, a nicotinic compound, water and may comprise one or more additional substances.
- The or each additional substance may individually be a biologically/pharmacologically active compound, one or more types of cellulose, pH stabilisers or adjusters, humectants, flavourants, fillers, preservatives, aqueous/non-aqueous solvents and binders. The or each additional substance may be provided for more than one purpose.
- The contents of the pouch (i.e. the ingredients, material and/or substances enclosed within the pouch) preferably occupies substantially all of the internal volume of the pouch. The contents may occupy 80%, 85%, 90%, 95% or 100% of the internal volume of the pouch. The contents may comprise a solid material to provide physical integrity, such as an organic material (e.g. plant material) or an inorganic material. Such solid materials may naturally or inherently contain one or more biologically/pharmacologically active compounds and/or additives.
- Biologically/pharmacologically active compounds are provided to produce a pharmacological effect in the user. Suitable biologically/pharmacologically active compounds include the group consisting of: nicotine, cocaine, caffeine, opiates and opioids, cathine and cathinone, kavalactones, mysticin, beta-carboline alkaloids, salvinorin A together with any combinations, functional equivalents to, and/or synthetic alternatives of the foregoing. Biologically/pharmacologically active compounds may also have additive properties.
- In some embodiments the contents include an active compound comprising nicotine and wherein the form of nicotine is selected from the group consisting of nicotine salts, nicotine base, stabilized nicotine and mixtures thereof. For example, the contents may include at least one nicotine salt selected from the group consisting of nicotine hydrochloride, nicotine dihydrochloride, nicotine monotartrate, nicotine ditartrate, nicotine ditartrate dihydrate, nicotine sulfate, nicotine zinc chloride monohydrate, nicotine salicylate and mixtures thereof.
- One or more types of cellulose can be selected from microcrystalline cellulose (MCC), methyl cellulose (MC), ethyl cellulose (EC), hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC) and carboxymethyl cellulose (CMC). In some embodiments, the contents comprise the powdered cellulose, a nicotinic compound, and microcrystalline cellulose. MCC is particularly effective when it comes to reducing the rate of nicotine release from the pouch during use. Suitable MCC for use in the invention includes Avicel® PH-102 available from DuPont.
- In some examples, the one or more types of cellulose is microcrystalline cellulose (MCC). As used herein, the term microcrystalline cellulose is a purified, partially depolymerised cellulose prepared by treating α-cellulose, obtained as a pulp from strains of fibrous plant material. Suitable types of MCC are know to the skilled person.
- In some examples, the one or more types of cellulose are in the form of particles having a D50 particle size of at least 30 µm, for examples at least 40 µm, at least 50 µm, at least 60 µm, at least 70 µm, at least 80 µm, at least 90 µm, at least 100 µm, at least 110 µm, at least 120 µm, at least 130 µm, at least 140 µm, at least 150 µm, at least 160 µm, at least 170 µm, or at least 180 µm. In some examples, the one or more types of cellulose are in the form of particles having a D50 particle size of up to 500 µm, for example up to 500 µm, up to 450 µm, up to 400 µm, up to 350 µm, up to 300 µm, up to 290 µm, up to 280 µm, up to 270 µm, up to 260 µm, up to 250 µm, up to 240 µm, up to 230 µm, or up to 220 µm.
- In some embodiments, the one or more types of cellulose are in the form of particles having a D50 particle size of from 30 to 500 µm, for examples from 100 to 500 µm or from 150 to 250 µm. In some embodiments, the one or more types of cellulose are in the form of particles having a D50 particle size of about 100 µm. In some embodiment, the cellulose is microcrystalline cellulose type 102 (MCC 102).
- In some embodiments, the one or more types of cellulose are in the form of particles having a D50 particle size of about 200 µm.
- In some examples, the content of the smokeless article comprises from 0 to 40 wt% one or more types of cellulose, for examples from 0 to 35 wt%, from 0 to 30 wt%, from 0 to 25 wt%, from 0 to 20 wt%, from 5 to 30 wt%, from 5 to 25 wt%, from 5 to 20 wt %, or from 10 to 20 wt% based on the total weight of the content.
- In some examples, the content of the smokeless article comprises at least 5 wt% one or more types of cellulose, for examples at least 10 wt%, at least 15 wt%, at least 20 wt% based on the total weight of the content.
- pH stabilisers or adjusters may be provided to adjust the user experience and/or modify the bicavailability of a pharmacologically active compound. For instance, under acidic conditions, nicotine is protonated and does not readily cross mucous membranes. Examples of suitable pH stabilisers include ammonia, ammonium carbonate, sodium carbonate and calcium carbonate. The overall pH of the smokeless article is preferably pH 7 to pH 9, such as pH 7.25 to pH 8.75 or pH 7.5 to pH 8.5.
- The overall pH of a smokeless article may be determined by, for example, (i) placing the smokeless article in 10 mL of distilled water (ii) agitating the mixture for at least 5 minutes and (iii) measuring the pH of the solution with a pH probe.
- In some examples, the content comprises a pH modifier (e.g. sodium carbonate) in an amount of from 0 wt% to 1 wt%, for example from 0.01 wt% to 1 wt%, from 0.01 wt% to 0.5 wt%, from 0.01 wt% to 0.2 wt%, from 0.01 wt% to 0.1 wt%, from 0.01 wt% to 0.08 wt%, or from 0.01 wt% to 0.06 wt% based on the total weight of the content.
- The pH modifier may have a lower limit of at least 0.01 % by weight of the contents such as at least 0.02 wt%, such as at least 0.03 wt%, such as at least 0.04 wt%, such as at least 0.05 wt%, or such as least 0.06 wt%.
- Fillers may be provided to increase the volume of the smokeless article (e.g. by increasing the volume contained within the pouch and to strengthen the contents). Suitable fillers include calcium carbonate, calcium phosphate, corn starch, grains, lactose, polysaccharides (e.g. maltodextrin), polyols, sugars (e.g. dextrose, manitol, xylitol, sorbitol), natural fibres (e.g. non-tobacco fibres), microcrystalline cellulose, cellulose and cellulose derivatives (e.g. finely divided cellulose), lignocellulose fibres (e.g. wood fibres), jute fibres and combinations thereof. In some cases, the filler content is 5 to 10 wt% of the contents e.g. around 6 to 9 wt%.
- Flavourants may be provided in solid or liquid form. Suitable flavourants include coffee, eucalyptus, menthol, liquorice, peppermint, spearmint, chocolate, fruit flavour (including e.g. citrus, cherry etc.), vanilla, spice (e.g. ginger, cinnamon) and tobacco flavour. The flavourant may be evenly dispersed throughout the contents or may be provided in isolated locations and/or varying concentrations throughout the contents.
- As used herein, the term "flavourant" denotes a compound having a desirable taste, aroma or both.
- In some examples, the content comprises one or more flavourants (e.g. peppermint flavour) in an amount of from 0 wt% to 10 wt%, for example from 1 wt% to 10 wt%, from 1 wt% to 8 wt%, from 1 wt% to 6 wt%, or from 2 wt% to 6 wt% based on the total weight of the content.
- Humectants may be provided to control moisture content thereby preventing the smokeless article from drying out during storage and reducing the amount of saliva wetting required before the user experience begins. Suitable humectants include polyhydric alcohols (e.g. propylene glycol (PG), triethylene glycol, 1 ,2-butane diol and vegetable glycerine (VG)) and their esters (e.g. glycerol mono-, di- or tri-acetate).
- The humectant may have a lower limit of at least 1 % by weight of the contents such as at least 2 wt%, such as at least 5 wt%, such as at least 10 wt%, such as at least 20 wt%, such as at least 30 wt%, or such as least 40 wt%.
- The humectant may have an upper limit of at most 50% by weight of the contents, such as at most 40 wt%, such as at most 30 wt%, or such as at most 20 wt%, such as at most 10 wt %, such as at most 5 wt %, such as at most 2 wt%.
- Preferably, the amount of humectant is 1 to 40 wt% of the contents, such as 2 to 20 wt% or 5 to 10 wt%.
- Smokeless articles having a total moisture content of 10% or less are generally considered to be 'dry'. Smokeless articles having a total moisture content of 40% or more are generally considered to be `wet'.
- Sweeteners may be provided to modify the user taste perception and, in particular, overcome bitter flavours that result from other substances. Suitable sweeteners include honey, sugar, brown sugar, glucose, fructose, sucrose, aspartame, xylitol, maltitol, saccharin sodium, glycyrrhizin tripotassium liquorice, jujube or a mixture thereof.
- In some examples, the content comprises a sweetener (e.g. acesulfame K) in an amount of from 0 wt% to 1 wt%, for example from 0.01 wt% to 1 wt%, from 0.01 wt% to 0.5 wt%, from 0.01 wt% to 0.2 wt%, from 0.01 wt% to 0.1 wt%, or from 0.01 wt% to 0.08 wt% based on the total weight of the content.
- The sweetener may have a lower limit of at least 0.01 % by weight of the contents such as at least 0.02 wt%, such as at least 0.03 wt%, such as at least 0.04 wt%, such as at least 0.05 wt%, or such as least 0.06 wt%.
- Stabilisers are provided to prevent decomposition or degradation over time during storage by, for example, retarding oxidation or unwanted biological activity. Stabilisers may be selected from the group consisting of antioxidants including vitamin E, such as tocopherole, ascorbic acid, sodium pyrosulfite,
- butylhydroxytoluene, butylated hydroxyanisole, edetic acid and salts thereof; and preservatives including citric acid, tartaric acid, lactic acid, malic acid, acetic acid, benzoic acid, sorbic acid and salts thereof.
- Binders may be provided. Suitable binders include starches and/or cellulosic binders such as methyl cellulose, ethyl cellulose, hydroxypropyl! cellulose, hydroxyethyl cellulose and carboxymethyl cellulose, gums such as xanthan, guar, arabic and/or locust bean gum, organic acids and their salts such as alginic acid (sodium alginate), agar and pectins. In some embodiments the binder content is 5 to 10 wt% of the contents, e.g. around 6 to 9 wt% or 7 to 8 wt%.
- Colourants may be provided to modify the user impression of the smokeless article. Colourants include whitening agents. Colourants may be selected from one or more of common colourants such as curcumin (E100), turmeric (E100(ii)), riboflavin (E101), riboflavin-5'-phosphate (E101(ii)), tartrazine (E102), quinoline yellow (E104), riboflavin-5-sodium phosphate (E106), yellow 2G (E107), sunset yellow FCF (E110), carmine, cochineal (E120), azorubine (E122), amaranth (E123), ponceau 4R (E124), erythrosine (E127), red 2G (E128), allura red AC (E129), patent blue V (E131), indigotine (E132), brilliant blue FCF (E133) chlorophylls (E140), copper complexes of chlorophyll (E141), green S (E142), caramel (E150a-d), brilliant black BN (E151), carbon (E153), brown FK (E154), brown HT (E155), alfa-, beta- and gamma- carotene (E160a), annatto, bixin, norbixin (E160b), bell pepper (Paprika) extract (E160c), lycopene (E160d), beta- apo-8'-carotenal (E160e), ethyl ester of beta-apo-8'-carotenic acid (E160f), flavoxanthin (E161a), lutein (E161b), cryptoxanthin (E161c), rubixanthin (E161d), violaxanthin (E161e), rhodoxanthin (E161f), canthaxanthin (E1619), citranaxanthin (E161h), beetroot extract (E162), anthocyanins (E163), calcium carbonate (E170), titanium dioxide (E171), iron oxides (E172), aluminium (E173), silver (E174), gold (E175), lithol rubine BK (E180), tannins (E181). The amount of colourant may be up to about 3% by weight of the smokeless article, such as about 0.5% to about 2.5% or about 1% to about 2%.
- Plant material may be provided for physical integrity and may function as a natural source of substances such as, for example, biologically/pharmacologically active compounds, flavourants, pH stabilisers etc. The plant material may comprise least one plant material selected from the list including Amaranthus dubius, Arctostaphylos uva-ursi (Bearberry), Argemone mexicana, Amica, Artemisia vulgaris, Yellow Tees, Galea zacatechichi, Canavalia maritima (Baybean), Cecropia mexicana (Guamura), Cestrum noctumum, Cynoglossum virginianum (wild comfrey), Cytisus scoparius, Damiana, Entada rheedii, Eschscholzia califomica (California Poppy), Fittonia albivenis, Hippobroma longiflora, Humulus japonica (Japanese Hops), Humulus lupulus (Hops), Lactuca virosa (Lettuce Opium), Laggera alata, Leonotis leonurus, Leonurus cardiaca (Motherwort), Leonurus sibiricus (Honeyweed), Lobelia cardinalis, Lobelia inflata (Indian-tobacco), Lobelia siphilitica, Nepeta cataria (Catnip), Nicotiana species (Tobacco), Nymphaea alba (White Lily), Nymphaea caerulea (Blue Lily), Opium poppy, Passiflora incamata (Passionflower), Pedicularis densiflora (Indian Warrior), Pedicularis groenlandica (Elephant's Head), Salvia divinorum, Salvia dorrii (Tobacco Sage), Salvia species (Sage), Scutellaria galericulata, Scutellaria lateriflora, Scutellaria nana, Scutellaria species (Skullcap), Sida acuta (Wireweed), Sida rhombifolia, Silene capensis, Syzygium aromaticum (Clove), Tagetes lucida (Mexican Tarragon), Tarchonanthus camphoratus, Tumera diffusa (Damiana), Verbascum (Mullein), Zamia latifolia (Maconha Brava) together with any combinations, functional equivalents to, and/or synthetic alternatives of the foregoing.
- In some examples, the plant material comprises or consist of one or more of wheat fibres, cellulose fibres, bamboo fibres, pine fibres and eucalyptus fibres.
- In some examples, the plant material is bamboo fibres. The bamboo fibres may have a particle size of 10-500 µm, for example 10-450 µm, 10-400 µm, 10-350 µm, 10-300 µm, 10-250 µm, 10-200 µm, 10-150 µm, 10-100 µm, 10-50 µm, 15-50 µm, 10-450 µm, 15-45 µm, 20-50 µm, 20-45 µm, 20-40 µm, or 25-35 µm. In some embodiments, the bamboo fibres have a particle size of about 30 µm.
- In some embodiments, the bamboo fibres have a particle size of 15-500 µm, for example, 20-500 µm, 50-500 µm, 100-500 µm, 150-500 µm, 200-500 µm, 250-500 µm, 250-450 µm, 250-400 µm, 250-350 µm, 260-340 µm, 270-330 µm, 280-320 µm, 290-310 µm, or 295-305 µm. In some embodiments, the bamboo fibres have a particle size of about 300 µm.
- In some embodiments, the bamboo fibres have a particle size of 30-300 µm.
- In some embodiments, the bamboo fibres are nicotine-dosed bamboo fibres.
- In some embodiments, the nicotine-dosed bamboo fibres comprise a nicotinic compound selected from nicotine, nicotine salts(s), nicotine complex(es), and nicotine solvate(s). In some embodiments, the nicotinic compound is provided in a plant material. In some embodiments, the plant material is tobacco.
- As used herein, the term "particle size" when referring to fibres such as bamboo fibres indicates the maximum size of the longest dimension of the fibres. For example, a particle size of 50 µm indicates that in the population of fibres, the maximum fibre length is 50 µm.
- Particles having the desired particle size may be obtained by passing a population of fibres through a sieve of corresponding mesh size. For example, to obtain fibres of particle size 300 µm (i.e. a maximum fibre length of 300 µm), a population of fibres are passed through a sieve with 300 µm diameter apertures in the mesh. In this way, fibres with a length of 300 µm or less pass through the mesh and fibres longer than 300 µm are retained by the mesh. The fibres which pass through the mesh may then be used in the smokeless article of the invention, having a particle size of 300 µm. Fibres of a desired particle size are also available from commercial suppliers such as Jelu-werk.
- As used herein, the term "bamboo fibres" refers to natural fibres from plants of the Bambusoideae subfamily of the Poaceae family of grasses. The fibres may originate from any part of the plant, but in some embodiments may be originate from the stem of the plant. The fibres may be obtained from commercial sources such as JELUCEL® BF fibres sold by Jelu-werk, or may be prepared by grinding or milling plant material until fibers of the required particle size are obtained.
- As used herein, the term "nicotine-dosed bamboo fibres" refers to a composition comprising bamboo fibres and a nicotinic compound. The nicotinic compound may be added to or mixed with the bamboo fibres prior to incorporation into the smokeless article. In some embodiments, the bamboo fibres are loaded into a suitable dryer, sprayed with a solution of nicotinic compound and dried to form nicotine-dosed bamboo fibres. The dryer may be a fluidised bed dryer. The solution may be a solution of nicotinic compound in glycerin. In some embodiments, the solution of nicotinic compound in glycerin may comprise from 10 to 50 wt% nicotinic compound based on the total solution weight, for example from 10 to 40 wt% or from 10 to 30 wt%.
- Any suitable parts of the tobacco plant may be used. This includes leaves, stems, roots, bark, seeds and flowers.
- The tobacco may comprise one or more of leaf tobacco, stem tobacco, tobacco powder, tobacco dust, tobacco derivatives, expanded tobacco, homogenised tobacco, shredded tobacco, extruded tobacco, cut rag tobacco and/or reconstituted tobacco (e.g. slurry recon or paper recon).
- The contents may comprise at least 50 wt% plant material based on the weight of the contents, e.g. at least 60 wt% plant material e.g. around 65 wt% plant material. The contents may comprise 80 wt% or less plant material e.g. 75 or 70 wt% or less plant material.
- The contents may comprise a gathered sheet of homogenised (e.g. paper/slurry recon) tobacco or gathered shreds/strips formed from such a sheet.
- The sheet may have a grammage greater than or equal to 100 g/m2, e.g. greater than or equal to 110 g/m2 such as greater than or equal to 120 g/m2. The sheet may have a grammage of less than or equal to 300 g/m2 e.g. less than or equal to 250 g/m2 or less than or equal to 200 g/m2. The sheet may have a grammage of between 120 and 190 g/m2.
- In some examples, the content comprises or consists of:
- powdered cellulose, wherein the powdered cellulose has an average particle size of 100-500 µm, in an amount of from 10 wt% to 50 wt%, for example from 20 wt% to 45 wt%, based on the total weight of the content;
- water, in an amount of from 40 wt% to 60 wt%, for example from 40 wt% to 50 wt%, based on the total weight of the content; and
- plant fibres (e.g. bamboo fibres), in an amount of from 0 wt% to 50 wt%, for example from 10 wt% to 30 wt%, based on the total weight of the content.
- In some examples, the content comprises or consists of:
- powdered cellulose, wherein the powdered cellulose has an average particle size of 100-500 µm, in an amount of from 10 wt% to 50 wt%, for example from 20 wt% to 45 wt%, based on the total weight of the content;
- water, in an amount of from 40 wt% to 60 wt%, for example from 40 wt% to 50 wt%, based on the total weight of the content; and
- glycerine, in an amount of from 5 wt% to 20 wt%, for example from 5 wt% to 10 wt%, based on the total weight of the content.
- In some examples, the content comprises or consists of:
- powdered cellulose, wherein the powdered cellulose has an average particle size of 100 - 500 µm, in an amount of from 10 wt% to 50 wt%, for example from 20 wt% to 45 wt%, based on the total weight of the content;
- water, in an amount of from 40 wt% to 60 wt%, for example from 40 wt% to 50 wt%, based on the total weight of the content;
- glycerine, in an amount of from 5 wt% to 20 wt%, for example from 5 wt% to 10 wt%, based on the total weight of the content; and
- plant fibres (e.g. bamboo fibres), in an amount of from 0 wt% to 30 wt%, for example from 10 wt% to 25 wt%, based on the total weight of the content.
- A second aspect of the invention is the use of powdered cellulose having an average particle size of 100-500 µm in a smokeless article, to improve powder flow, improve mouth feel, and/or improve nicotine perception.
- A third aspect of the invention is a process of manufacturing the smokeless article according to the first aspect, comprising the steps of:
- (i) forming one or more sheets of pouch material around the contents; and,
- (ii) thermally or chemically sealing the pouch material to enclose the contents.
- A fourth of the invention is a kit comprising a plurality of smokeless articles according to the first aspect and a container.
- A fifth aspect of the invention is a smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and an active agent and/or flavourant; wherein the content satisfies one or more of the following:
- (a) a Carr's Index of less than 42;
- (b) a Hausner's ratio of less than 1.75;
- (c) a bulk density of 0.20-0.40 g/mL;
- (d) a tapped density of 0.35-0.60 g/mL.
- In some examples, the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30.
- In some examples, the content has a Carr's Index of from 25 to 42, for example 29 to 42, 30 to 42, 30 to 40, 30 to 39 or 33 to 39.
- In some examples, the content has a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35.
- In some examples, the content has a Hausner's ratio of from 1.35 to 1.74, for example 1.38 to 1.74, 1.40 to 1.74, 1.40 to 1.70, 1.45 to 1.70, 1.45 to 1.65 or 1.50 to 1.65.
- In some examples, the content has a Carr's Index of less than 42, for example less than 41, less than 40, less than 39, less than 37, less than 36, less than 35, less than 34, less than 33, less than 32, less than 31, or less than 30; and a Hausner's ratio of less than 1.75, for example less than 1.72, less than 1.70, less than 1.65, less than 1.64, less than 1.60, less than 1.55, less than 1.50, less than 1.45, less than 1.40, or less than 1.35. In some examples, the content has a Carr's Index of less than 40; and a Hausner's ratio of less than 1.65.
- In some examples, the content has a bulk density above about 0.20 g/mL, for example above about 0.21 g/mL, above about 0.22 g/mL, or above about 0.24 g/mL.
- In some examples, the content has a bulk density up to about 0.40 g/mL, for example up to about 0.38 g/mL, up to about 0.36 g/mL, up to about 0.34 g/mL, or up to about 0.338 g/mL.
- In some examples the content has a bulk density of 0.20-0.40 g/mL, 0.24-0.40 g/mL, 0.24-0.38 g/mL, 0.24-0.36 g/mL, 0.24-0.34 g/mL, or 0.242-0.337 g/mL.
- In some examples, the content has a tapped density above about 0.35 g/mL, for example above about 0.36 g/mL, above about 0.38 g/mL, or above about 0.39 g/mL.
- In some examples, the content has a tapped density up to about 0.60 g/mL, for example up to about 0.58 g/mL, up to about 0.56 g/mL, up to about 0.54 g/mL, or up to about 0.51 g/mL.
- In some examples the content has a tapped density of 0.35-0.60 g/mL, 0.36-0.58 g/mL, 0.38-0.55 g/mL, 0.38-0.52 g/mL, 0.39-0.51 g/mL, or 0.394-0.505 g/mL.
- In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65 and a bulk density of 0.20-0.40 g/mL. In some examples, the content has a Carr's Index of less than 40, a Hausner's ratio of less than 1.65, a bulk density of 0.20-0.40 g/mL and a tapped density of 0.35-0.60 g/mL.
- Tapped density can be measured using the method described in the Examples.
- All the options and preferences set out above in relation to the smokeless article of the fist aspect apply equally to the smokeless article of the fifth aspect, but for brevity are not repeated here.
- The skilled person will appreciate that except where mutually exclusive, a feature or parameter described in relation to any one of the above aspects may be applied to any other aspect. Furthermore, except where mutually exclusive, any feature or parameter described herein may be applied to any aspect and/or combined with any other feature or parameter described herein.
- The preceding summary is provided for purposes of summarizing some examples to provide a basic understanding of aspects of the subject matter described herein. Accordingly, the above-described features should not be construed to narrow the scope or spirit of the subject matter described herein in any way. Moreover, the above and/or proceeding examples may be combined in any suitable combination to provide further examples, except where such a combination is clearly impermissible or expressly avoided. Other features, aspects, and advantages of the subject matter described herein will become apparent from the following text and the accompanying drawings.
- Aspects, features and advantages of the present disclosure will become apparent from the following description of examples in reference to the appended drawings in which like numerals denote like elements.
-
Figure 1 shows a cross sectional view of a first embodiment of a smokeless article. -
Figure 2 shows a cross sectional view of a second embodiment of a smokeless article. -
Figure 3 shows a cross sectional view of a third embodiment of a smokeless article. -
Figure 4 shows a cross sectional view of a fourth embodiment of a smokeless article. -
Figure 5 is a plot of Hausner's Ratio against amount of powdered cellulose (Arbocel A300) for Examples 1 and 2 and Comparative Example 1. -
Figure 6 is a plot of Carr's Index against amount of powdered cellulose (Arbocel A300) for Examples 1 and 2 and Comparative Example 1. -
Figure 7 is a plot of density (bulk and tapped) against amount of powdered cellulose (Arbocel A300). - As shown in
Figure 1 there is provided a first embodiment of asmokeless article 10 having apouch 12 containingcontents 14. Thepouch 12 is substantially rectangular. Thepouch 12 is formed from a single sheet of material and is substantially filled by thecontents 14. Thepouch 12 has aseal 16 along each of the three edges where the inner face of the single sheet meets itself to seal thecontents 14 in thepouch 12. -
Figure 2 shows a second embodiment of a smokeless article 10' having apouch 12 containingcontents 14. Thepouch 12 is substantially circular. Thepouch 12 is formed from two opposing sheets of material and is substantially filled by thecontents 14. The pouch has acircumferential seal 16 along the edges where the two opposing sheets of material meet to seal thecontents 14 in thepouch 12. -
Figure 3 shows a third embodiment of asmokeless article 10" that, like the first embodiment, has apouch 12 made from a single sheet of material. However, one of the three seals 16' is formed by an overlap of the inner face and the outer face of the single sheet meet to seal thecontents 14 in thepouch 12. The remaining two seals at opposing ends of thepouch 12 are formed where the inner face of the single sheet meets itself. -
Figure 4 shows a fourth embodiment of a smokeless article 10'" that comprises the third embodiment enclosed byouter pouch 12" having anouter contents 14" positioned in the space between the inner pouch 12' and theouter pouch 12". Theouter pouch 12" also has a circumferential seal 16'" to seal theouter contents 14" and inner pouch 12' in theouter pouch 12". - Use of the second embodiment begins when the smokeless article 10'" is placed in the user's mouth where it is exposed to saliva. Saliva first permeates
outer pouch 12" and dissolves and extracts the saliva soluble substances ofouter contents 14". Upon leaving theouter pouch 12", the saliva soluble substances ofouter contents 14" therefore provide the user with a first experience. Saliva subsequently further permeates the inner pouch 12' where it dissolves and extracts the saliva soluble substances of inner contents 14'. The saliva soluble substances of inner contents 14' therefore provide the user with a complimentary and secondary experience. When the extractable amount of saliva soluble substances in the inner contents 14' andouter contents 14" drops below perceivable levels the active lifetime of the smokeless article 10'" has ended. -
Figure 5 shows that there is a negative correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the Hausner's Ratio of the content. In other words, as the percentage of powdered cellulose is increased, the flowability of the content is improved. -
Figure 6 shows that there is a negative correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the Carr's Index of the content. In other words, as the percentage of powdered cellulose is increased, the compressibility of the content is improved. -
Figure 7 shows that there is a positive correlation between the percentage of powdered cellulose (Arbocel A300) used in the content, relative to the total amount of plant-based filler (powdered cellulose and bamboo fibres) and the density (both bulk and tapped) of the content. In other words, as the percentage of powdered cellulose is increased, the compressibility of the content is improved. - Before describing several examples implementing the present disclosure, it is to be understood that the present disclosure is not limited by specific construction details or process steps set forth in the following description and accompanying drawings. Rather, it will be apparent to those skilled in the art having the benefit of the present disclosure that the systems, apparatuses and/or methods described herein could be embodied differently and/or be practiced or carried out in various alternative ways.
- Unless otherwise defined herein, scientific and technical terms used in connection with the presently disclosed inventive concept(s) shall have the meanings that are commonly understood by those of ordinary skill in the art and known techniques and procedures may be performed according to conventional methods well known in the art and as described in various general and more specific references that may be cited and discussed in the present specification.
- Any patents, published patent applications, and non-patent publications mentioned in the specification are hereby incorporated by reference in their entirety.
- All examples implementing the present disclosure can be made and executed without undue experimentation in light of the present disclosure. While particular examples have been described, it will be apparent to those of skill in the art that variations may be applied to the systems, apparatus, and/or methods and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit, and scope of the inventive concept(s). All such similar substitutions and modifications apparent to those skilled in the art are deemed to be within the spirit, scope, and concept of the inventive concept(s) as defined by the appended claims.
- The use of the term "a" or "an" in the claims and/or the specification may mean "one," as well as "one or more," "at least one," and "one or more than one." As such, the terms "a," "an," and "the," as well as all singular terms, include plural referents unless the context clearly indicates otherwise. Likewise, plural terms shall include the singular unless otherwise required by context.
- The use of the term "or" in the present disclosure (including the claims) is used to mean an inclusive "and/or" unless explicitly indicated to refer to alternatives only or unless the alternatives are mutually exclusive. For example, a condition "A or B" is satisfied by any of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present).
- As used in this specification and claim(s), the words "comprising, "having," "including," or "containing" (and any forms thereof, such as "comprise" and "comprises," "have" and "has," "includes" and "include," or "contains" and "contain," respectively) are inclusive or open-ended and do not exclude additional, unrecited elements or method steps.
- Unless otherwise explicitly stated as incompatible, or the physics or otherwise of the embodiments, examples, or claims prevent such a combination, the features of examples disclosed herein, and of the claims, may be integrated together in any suitable arrangement, especially ones where there is a beneficial effect in doing so. This is not limited to only any specified benefit, and instead may arise from an "ex post facto" benefit. This is to say that the combination of features is not limited by the described forms, particularly the form (e.g. numbering) of example(s), embodiment(s), or dependency of claim(s). Moreover, this also applies to the phrase "in one embodiment," "according to an embodiment," and the like, which are merely a stylistic form of wording and are not to be construed as limiting the following features to a separate embodiment to all other instances of the same or similar wording. This is to say, a reference to 'an,' 'one,' or 'some' embodiment(s) may be a reference to any one or more, and/or all embodiments, or combination(s) thereof, disclosed. Also, similarly, the reference to "the" embodiment may not be limited to the immediately preceding embodiment. Further, all references to one or more embodiments or examples are to be construed as non-limiting to the claims.
- Example 1 was prepared containing powdered cellulose with an average particle size of 320 µm (ARBOCEL® A300). Example 1 contained the following components:
Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 21.90 131.84 32.85 Arbocel A300 Bulking Agent (Snus Substitute) 21.90 131.84 32.85 Peppermint flavour Flavour Extract 4.00 24.08 6.00 Total 100.00 602.01 150.00 - Arbocel A300 is powdered cellulose supplied by Pharma Excipients. BF-300 is JELUCEL® BF-300 bamboo fibres supplied by Jelu-werk.
- Example 2 was prepared containing powdered cellulose with an average particle size of 320 µm (ARBOCEL® A300). Example 2 contained the following components:
Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 0.00 0.00 0.00 Arbocel A300 Bulking Agent (Snus Substitute) 43.80 263.68 65.70 Peppermint flavour Flavour Extract 4.00 24.08 6.00 Total 100.00 602.01 150.00 - Comparative Example 1 was prepared containing no powdered cellulose (only bamboo fibres were used as bulking agent). Comparative Example 1 contained the following components:
Material Purpose %w/w mg/Dose g/Batch Nicotine Active 0.70 4.21 1.05 Glycerine Humectant 6.30 37.93 9.45 Water Solvent 45.06 271.26 67.59 Sodium Carbonate pH Modifier 0.06 0.37 0.09 Acesulfame K Sweetener 0.08 0.48 0.12 BF-300 Bulking Agent (Snus Substitute) 43.80 263.68 65.70 Arbocel A300 Bulking Agent (Snus Substitute) 0.00 0.00 0.00 Peppermint flavour Flavour Extract 4.00 24.08 6.00 Total 100.00 602.01 150.00 - The compositions of Example 1, Example 2, and Comparative Example 1 were each prepared using the following method (Protocol A):
- 1. All the materials were dispensed into appropriately sized beakers using a 2 d.p. balance to determine the weights.
- 2. All the liquid components (Nicotine dissolved in the glycerine, Acesulfame K Solution, Sodium Carbonate solution) were added into the beaker containing the water dispensed in the previous step. This was then transferred onto a magnetic stirrer and mixed for approx. 10 mins using a magnetic stirrer bar until the solution appeared homogeneous.
- 3. While the above solution was mixing, the bulking agent (Arbocel and/or BF-300) was added to a Kenwood food processor, this then was mixed for ∼1 min at full speed.
- 4. The solution prepared in step 2 was slowly added to the Kenwood food preocessor over the course of ∼3-4 mins while still mixing. After this the Kenwood was stopped, opened, and the sides and bottom of the bowl were scraped.
- 5. The Kenwood was then restarted at full power. The peppermint flavour was added to the blend over the course of ∼1-2 mins.
- 6. The Kenwood was then stopped again, opened, and the sides and bottom of the bowl were scraped. The Kenwood was then restarted at full power and mixed for ∼1-2 mins. The Kenwood was shaken while this was happening to ensure complete mixing.
- 7. Finally, the blend was transferred to a foil pouch for storage.
- Carr's Index, Hausner's Ratio, bulk density and tapped density were determined for each of Examples 1-2 and Comparative Example 1, according to the following method based on Ph. Eur. 2.9.34.
- 1. A 100 mL Cylinder was placed on to a 2 d.p. balance, and tared.
- 2. Using a beaker, test powder was transferred into the 100 mL cylinder at approx. 90-degree angle until the cylinder was filled to approx. 90-100mL.
- 3. The volume (V0) was recorded, before tapping. The cylinder was then gently placed back on to the balance and the net weight of the contents was then recorded. The density calculated using V0 and the net weight is the bulk density.
- 4. The cylinder was then placed on to a JV1000 density tester, and tapped 10 times, after which the volume was recorded as (V10).
- 5. The cylinder was tapped another 490 times, and once again the volume was recorded as (V500).
- 6. This was repeated, but the cylinder was tapped a further 750 times and the volume recorded once again as (V1250).
- 7. If the volume of the powder in the cylinder dropped by more than 1 cm, then the cylinder was tapped a further 1250 times, this was then repeated until the volume in the cylinder dropped by no more than 1cm.
- 8. This whole procedure was repeated, and averages of the bulk and tapped densities were calculated.
- 9. The results of the above were used to calculate the Carr's index and Hasuners Ratio as per the calculations below. The lower these numbers are the better the flow of the blends is.
- The results are provided in the Table below:
Example Bulk Density / g ml-1 Tapped Density / g ml-1 Carr's Index Hausner's Ratio Example 1† 0.242 0.394 38.6 1.63 Example 2† 0.337 0.505 33.4 1.50 Comparative Example 1† 0.151 0.265 42.8 1.75 † Prepared at lab-scale following the method of Protocol A - The results show that, when powdered cellulose is present in the composition, the powder properties (Carr's Index and Hausner's ratio) are improved. The same improvement is not seen when powdered cellulose is absent.
- The Hausner's ratio of Examples 1 and 2 and Comparative Example 1 are plotted in
Figure 5 . There is a linear decrease in the Hausner's ratio as the % powdered cellulose (as a proportion of the total amount of powdered cellulose and bamboo fibres) increases. This shows that using powdered cellulose, in particular powdered cellulose having an average particle size of 100-500 µm, e.g. about 320 µm, as a bulking agent instead of other plant-based fillers such as bamboo fibres improves the powder properties. - The Carr's Index of Examples 1 and 2 and Comparative Example 1 are plotted in
Figure 6 . There is a linear decrease in the Carr's Index as the % powdered cellulose (as a proportion of the total amount of powdered cellulose and bamboo fibres) increases. This shows that using powdered cellulose, in particular powdered cellulose having an average particle size of 100-500 µm, e.g. about 320 µm, as a bulking agent instead of other plant-based fillers such as bamboo fibres improves the powder properties. - It would be expected that that the Carr's Index and Hausner's Ratio would decrease further when moving the production from lab-scale to factory scale. More specifically, the Carr's index can be expected to decrease by ∼11 % and the Hausner's Ratio can be expected to decrease by ∼8 %.
- Thus when Example 2 is prepared on a factory scale the Carr's Index and Hausner's Ratio could be expected to be further improved to around 29.7 and 1.38 respectively.
- Another important aspect associated with the use of powdered cellulose is the increase in density. This means that during manufacture of the product, the feedstock occupies a smaller volume, and a larger mass of fibres may be processed per unit time. This increases manufacturing capacity, reducing the overall production cost for the product and increasing efficiency of the manufacturing process.
- The higher density means that the pouch may be smaller while carrying the same mass of fibre. This means that the amount of material used to manufacture the pouch per smokeless article is reduces, which reduces manufacturing cost.
- Furthermore, according to test subjects, the use of powdered cellulose improved the mouth feel of the smokeless article compared to products that do not contain powdered cellulose.
Claims (15)
- A smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and an active agent and/or flavourant, wherein the powdered cellulose has an average particle size of 100-500 µm.
- The smokeless article according to claim 1, wherein the powdered cellulose has an average particle size of 200-400 µm.
- The smokeless article according to claim 1 or 2, wherein the powdered cellulose has an average particle size above 300 µm, optionally wherein the powdered cellulose has an average particle size of about 320 µm.
- The smokeless article according to any of claims 1 to 3, wherein the powdered cellulose has a bulk density of 0.30-0.45 g/mL.
- The smokeless article according to any one of claims 1 to 4, wherein the powdered cellulose comprises a mechanically processed cellulose derivative with a fibrous structure.
- The smokeless article according to any one of claims 1 to 5, wherein the content comprises an active agent which comprises or consists of a nicotinic compound.
- The smokeless article according to claim 6, wherein the nicotinic compound is selected from nicotine, nicotine salt(s), nicotine complex(es), and nicotine solvate(s); optionally wherein the nicotinic compound is provided in a plant material, optionally wherein the plant material is tobacco.
- The smokeless article according to any one of claims 1 to 7, wherein the smokeless article is tobacco free.
- The smokeless article according to any one of claims 1 to 8, wherein the content comprises at least 20 wt% powdered cellulose.
- The smokeless article according to any one of claims 1 to 9, wherein the total nicotine content is from 5 to 15 mg, preferably about 10 mg.
- The smokeless article according to any one of claims 1 to 10, wherein the content has a Carr's Index of less than 42 and/or a Hausner's Ratio of less than 1.75.
- A smokeless article for oral consumption comprising a pouch enclosing a content, the content comprising powdered cellulose and an active agent and/or flavourant; wherein the content satisfies one or more of the following:(a) a Carr's Index of less than 42;(b) a Hausner's ratio of less than 1.75;(c) a bulk density of 0.20-0.40 g/mL;(d) a tapped density of 0.35-0.60 g/mL.
- The use of powdered cellulose and an active agent and/or flavourant, wherein the powdered cellulose has an average particle size of 100-500 µm, to improve powder flow, improve mouth feel, and/or improve the user's perception of the active agent and/or flavourant in a smokeless article for oral consumption; optionally wherein the smokeless article is according to any one of claims 1 to 12.
- A method of manufacturing a smokeless article according to any one of claims 1 to 12 comprising the steps of:(i) forming one or more sheets of pouch material around the contents; and,(ii) thermally or chemically sealing the pouch material to enclose the contents.
- A kit comprising a plurality of smokeless articles according to any one of claims 1 to 12 and a container.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP23190375.8A EP4505884A1 (en) | 2023-08-08 | 2023-08-08 | Smokeless article |
PCT/EP2024/072171 WO2025032058A1 (en) | 2023-08-08 | 2024-08-05 | Smokeless article |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP23190375.8A EP4505884A1 (en) | 2023-08-08 | 2023-08-08 | Smokeless article |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4505884A1 true EP4505884A1 (en) | 2025-02-12 |
Family
ID=87567573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP23190375.8A Pending EP4505884A1 (en) | 2023-08-08 | 2023-08-08 | Smokeless article |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP4505884A1 (en) |
WO (1) | WO2025032058A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130160782A1 (en) * | 2006-03-16 | 2013-06-27 | Niconovum Ab | Snuff composition |
US20210068447A1 (en) * | 2019-09-11 | 2021-03-11 | R. J. Reynolds Tobacco Company | Pouched products with enhanced flavor stability |
EP3868222A1 (en) * | 2020-02-18 | 2021-08-25 | Nerudia Limited | Smokeless article |
US20210307375A1 (en) * | 2019-06-07 | 2021-10-07 | Ncp Nextgen A/S | Nicotine pouch composition |
US20220408786A1 (en) * | 2021-06-25 | 2022-12-29 | Nicoventures Trading Limited | Oral products and method of manufacture |
EP4144231A1 (en) * | 2020-04-28 | 2023-03-08 | Japan Tobacco Inc. | Nicotine supply oral pouch product and production method therefor |
-
2023
- 2023-08-08 EP EP23190375.8A patent/EP4505884A1/en active Pending
-
2024
- 2024-08-05 WO PCT/EP2024/072171 patent/WO2025032058A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130160782A1 (en) * | 2006-03-16 | 2013-06-27 | Niconovum Ab | Snuff composition |
US20210307375A1 (en) * | 2019-06-07 | 2021-10-07 | Ncp Nextgen A/S | Nicotine pouch composition |
US20210068447A1 (en) * | 2019-09-11 | 2021-03-11 | R. J. Reynolds Tobacco Company | Pouched products with enhanced flavor stability |
EP3868222A1 (en) * | 2020-02-18 | 2021-08-25 | Nerudia Limited | Smokeless article |
EP4144231A1 (en) * | 2020-04-28 | 2023-03-08 | Japan Tobacco Inc. | Nicotine supply oral pouch product and production method therefor |
US20220408786A1 (en) * | 2021-06-25 | 2022-12-29 | Nicoventures Trading Limited | Oral products and method of manufacture |
Non-Patent Citations (1)
Title |
---|
DÜSENBERG BJÖRN ET AL: "Flowability of plant based food powders: Almond, chestnut, chickpea, coconut, hazelnut and rice", JOURNAL OF FOOD ENGINEERING, ELSEVIER, AMSTERDAM, NL, vol. 357, 5 June 2023 (2023-06-05), XP087370188, ISSN: 0260-8774, [retrieved on 20230605], DOI: 10.1016/J.JFOODENG.2023.111606 * |
Also Published As
Publication number | Publication date |
---|---|
WO2025032058A1 (en) | 2025-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3868222A1 (en) | Smokeless article | |
JP7600232B2 (en) | Oral nicotine pouch product including a filler material containing nicotine particles | |
US20220202071A1 (en) | Smokeless article | |
EP1458252B1 (en) | Tobacco and/or tobacco in combination with tobacco substitute composition for use as a snuff in the oral cavity | |
JP5694645B2 (en) | Improved snuff composition | |
Baker et al. | The effect of tobacco ingredients on smoke chemistry. Part II: casing ingredients | |
US20220248748A1 (en) | An oral pouched nicotine product including a filling material comprising nicotine-containing particles | |
US20020170567A1 (en) | Chewable flavor delivery system | |
US20170318858A1 (en) | A tobacco or non-tobacco product comprising magnesium carbonate | |
EP4106556A1 (en) | Smokeless article | |
KR20120083738A (en) | Capsule containing extract of persimmon | |
EP3861873A1 (en) | Container for smokeless article | |
EP4505884A1 (en) | Smokeless article | |
EP3868221A1 (en) | Smokeless article | |
EP3868223A1 (en) | Smokeless article | |
EP3868224A1 (en) | Smokeless article | |
EP4505883A1 (en) | Method of manufacturing a smokeless article | |
EP3837995A1 (en) | A smokeless article | |
US20220386685A1 (en) | Smokeless article | |
RU2832481C1 (en) | Smokeless product containing bamboo fibers with metered amount of nicotine, use of such fibers, method of making said product and kit containing smokeless product | |
JP2025510841A (en) | Compositions Comprising Aggregates Comprising Aerosol-Forming Materials and Uses Thereof - Patent application | |
EP4467010A1 (en) | Pouched product and method of making | |
EP4070671B1 (en) | A flavoured oral pouched nicotine product comprising an acid | |
US12295412B2 (en) | Oral pouch product | |
US20250194662A1 (en) | Nicotine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |